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SUMMARY
Normal ranges are essential for the interpretation of 
laboratory data. In order to recognise pathological processes 
early in the course of a disease these ranges need to be-efficient. 
Tne efficiency of the ranges used in the laboratory of the Royal 
Sussex County Hospital was questioned when biochemical profiling 
was introduced routinely using the Vickers M300 Multichannel 
analyser. The number of abnormal results was large and it was 
apparent that the normal ranges in use at that time, which 
were designed for a single test performed on a specially selected 
patient population, were not adequate for screening purposes.
The determination of new ranges however, posed several conceptual 
and practical problems which required resolution. Since there is 
no universally acclaimed method for determining these ranges 
several methods requiring simple mathematics and which appeared 
potentially useful for a laboratory without sophisticated 
computerisation, were evaluated. The effects of age and sex on 
these ranges were also investigated. Data from the hospital 
patient population were used in this work and the effects of 
data selection on the normal ranges was also evaluated.
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LIST OF SYMBOLS
Symbol Interpretation
X, Y Variables under discussion
x.y y. Independent values obtained by measurement or
1 observation of the variables X, Y etc respectively
x, y The means of sets of values obtained for
variables X, Y respectively.
Mean of a population. This may also be used to 
denote the prefix micro used in quantitative 
measurements of the order 1 x 10~^ units e.g. 
micromole (yumol).
N Number of observations in a population.
n Number of observations in a sample.
d.' Deviation of x. from x.
1 i
Standard deviation of a population.
s Standard deviation of a sample.
21 Sum of..
f Frequency.
cf Cumulative frequency.
df Degrees of freedom.
2 2
V(x) Variance of X (<5~ or s )
p Probability, 0 ^ p ^ 1
SE(x) Standard error of mean.
'Xj*~ Chi-squared.
R Rank.
In Natural logarithm, base e.
log Logarithm, base 10.
h Class interval.
A Change or difference between two successive values
t The t distribution and the statistic
t = (x -/0/( s/Vn) allows a probability to be
calculated for the difference betv/een tv/o means 
by comparison with the standard error of the means
GLOSSARY
Abnormal Range: This is a range of values located outside
the -normal range and which indicates some probability that 
a disease is present.
Cells or Glass Intervals: These are discrete divisions within
a continuous range of results of a given variable which allow 
data to be grouped and plotted as frequencies. In a frequency 
distribution the class intervals are usually described by their 
mid-points along the x-axis. There is no overlap between cells, 
and all experimental data are included.
Confidence Limits: Limits within which a parameter may be expected
to lie with some given probability. The limits may be expressed
as a confidence interval. For example,. 95 per cent confidence
limits of the mean define the limits of the range within which
there is 0.95 probability that the true mean will lie and for a
Normal sample of size n these limits are given by x + tn .... s/Vn— U.
Cost of Errors: This describes the consequence of a v/rongly
interpreted result and will, in clinical practice, affect the 
positions of the normal limits. If the cost of classifying 
an •abnormal result as normal is high then the normal range 
is reduced in order to minimise this eventuality. The cost is 
measured in terms of discomfort and stress to the patient and 
time and money to the hospital.
Disease: ’’The sum of the abnormal phenomena displayed by a
group of living organisms in association with a specified 
characteristic or set of characteristics by v/hich they differ 
from the norm for their species in such a way as to place them 
at a biological disadvantage.” (Scadding, 1967).
Fractile: A value below which lies a given fraction of a set
of data. For example, with the quartiles and 25 per
cent of the data fall below , 50 per cent of the data fall 
below Q2, and 75 per cent of the data fall below Q y  
Frequency Distribution: A graphical representation of a number
of observations of the same variable. The x-axis describes the 
range of results and the y-axis shows the frequency of 
observations within each class interval.
Health: The state produced by the sum of the biological
characteristics of an organism combining in such a way as not 
to place it at a disadvantage with respect to its environment.
The World Health Organisation has defined ’’health" as "a state 
of complete mental, physical and social well-being and not 
merely the absence of disease or infirmity".
Mode: The value which occurs most often in a sample or population
Normal Distribution: (also called a Gaussian distribution after
its originator). Originally described the pattern of variation 
observed in different measurements of the same item by the same 
instrument and technique. The distribution is continuous and 
may be defined by a curve which has the equation
y = _ i _  . e- ( ^ ) 2/2«r2
/( 2ir)
In a Normal Distribution the median, mean, and mode are coincident 
To avoid confusion with the term ’normal range’ in this thesis, 
the distribution is referred to as Gaussian throughout.
Normal Range: The most commonly occurring set of values in
a population. The limits of this range are arbitrarily chosen, 
but generally include the central 90 or 95 per cent of a symmetrical 
distribution. The choice of limits is dependent upon the type of 
sample, the specificity of the test for detection of disease and 
the statistical method used for the determination of the normal 
range. The central, most common range of values is, with most 
variables, taken to be consistent with good health.
Outlier: An observation that departs from expectation to an
improbable extent. (Barnett and Lewis, 1978, and Healy, 1979). 
Parametric: A method which requires calculation of a statistic
to estimate a parameter of a distribution. Methods which do not 
require calculation of such statistics are called ’non-parametric1. 
PercentileaFractile: -.The assigned number describes that part of the
distribution below the percentile; the 50 percentile has equal 
parts of the distribution on either side.
Population: The complete set of all possible observations or
measurements of the type which is being investigated.
Sample: A portion of material or a group of individuals or
specimens taken from the large mass or bulk which constitutes 
the population.
Screen or Profile: Medical investigations which do not arise
from a patient’s request for advice for a specific complaint 
(Wilson, 1969)•
Standard Deviation: The square root of the variance, which
for a Gaussian Distribution describes a fixed proportion of the 
area under the curve. The standard deviation estimated from a 
sample of size n -i s
non-Gaussian or asymmetric distributions into Gaussian or 
symmetrical distributions. The most commonly used method 
employs logarithms.
Variance: The mean of the square of deviations of values from
the mean „ 51
V(x) = <r = Jr (x-;u)J/K
The sample variance is an unbiased estimator of the population
variance, and uses the number of degrees of freedom, (n-1), as
the divisor so that
Transformation Methods: Techniques for the conversion of
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FOREWORD
Owing to the rapid increase in work load, clinical 
biochemistry laboratories throughout the United Kingdom were 
experiencing great difficulty in the 1960*s in meeting the 
demands for everyday analyses. This problem was particularly 
acute for those laboratory tests described by Marks (1972) 
as the "top twenty" and has been partly solved by the 
introduction of work-simplification and the development of 
new high-speed analytical machines. As a result of the 
development of these machines, the workload has increased 
further, Fig 1. As early as 1963 Marsh commented on the 
increasing use by hospital doctors in the United States of 
America of grouped ’screening* or admission tests. In 1965 
Anderson et al reported that many Scandinavian laboratories 
were offering ’package deals* of tests and the same 
considerations motivated Gaddie _et al (1966) to recommend 
grouped analyses using multiples of single-channel Auto-Analysers 
arranged to sample a single specimen.
- The biochemistry laboratory at the Royal Sussex County 
Hospital also experienced these problems so that in 1972 the 
Vickers high-speed multichannel analyser, the M300, was 
introduced. The tests most frequently requested by the 
clinicians were developed for the M300 profile. These tests 
included bilirubin, alkaline phosphatase, lactate dehydrogenase (LD), 
total protein, albumin, aspartate aminotransferase (AST).
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In 1979 the average number of tests per month had increased 
to 59,000, This was predominantly due to the development 
of Radio-immunoassay techniques.
calcium, phosphate, sodium, potassium and urea. It soon became 
apparent that there was a problem, also observed in other 
laboratories, concerning the interpretation of the results 
(Whitehead and Wootton, 1974)* The number of abnormal results 
seemed excessive and partly because of this the development 
and introduction of fast multichannel analysers has been 
received with mixed feelings. The machines were developed 
primarily to relieve the ever-increasing workload of the 
clinical chemistry laboratory, but unexpected benefits to 
the clinician may also be provided. Por example, the 
unrequested tests occasionally provide information of clinical 
importance, but there may also be results which do not fit the 
clinical picture, (Bailey, 1974, and Bradwell et al, 1974). 
Revision of the normal ranges for the M300 is the first step 
in an attempt to reduce the number of unexplained abnormals . 
Those results remaining outside the normal limits can then 
be interpreted more precisely and .if necessary the patient 
investigated further.
1.1 INTRODUCTION
Definition; 'Normal* or Reference? ..
The problem of defining 1 normality* is intimately 
connected with the development of instrumentation. The 
calculation of normal ranges has been required ever since 
the first quantitative physiological measurements were made 
by Sanctorius (1561-1636) who constructed the first crude 
but ingenious thermometer.
The word ’normal' as commonly used in medicine is ambiguous
Simonson (1965) considers that normal ranges in medicine
mean no more than a statistical prediction of being normal.
In this sense, the word means that which is commonly found.
The latin word 'normalis* from which 'normal* was derived means
according to pattern. Other interpretations include; "free
from infection or other forms of disease, malformation or from
experimental therapy or manipulation", (Stein, 1966); "typical,
usual, healthy, according to rule or standard", (Taylor, 1946);
"occurring naturally and not because of disease, inoculation or 
any. experimental treatment", (Neilson et al, 1960); "in medicine
and psychology, 'healthy', i.e. lacking observable or detectable
clinical abnormalities, deficiencies or diseases", (Hoerr and
Osol, 1956). These interpretations of normal are inconsistent
with the Oxford English Dictionary (1933) definition and have
evolved through the oversimplification that normal and healthy
are always interchangeable.
Amador, (1974) defined 'normality' in a more tangible 
manner. "The normal range is the statistically defined range 
(such as the central 95 per cent of values)
of a constituent, pattern or parameter measured in an adequate 
sample of subjects, of specified age and sex, in the absence 
of detectable disease, and measured by a specified method." 
Other investigators, however, have concluded that there is 
no absolute means of defining normal values or normal 
ranges, (Sunderman, 1975). Based upon a penetrating analysis 
of the subject, Benson (1972) wrote "The normal range has
had a vague but confusing role in laboratory medicine  and
is indeed one of the most stubborn and difficult problems 
limiting the usefulness of clinical laboratory data .....".
Murphy (1965) regarded 'normality' as a concept with 
each normal range having a frame of reference describing 
the data and the statistical techniques used for its 
calculation. Without this frame of reference certain 
situations may produce misleading results* For instance, in 
a population where goitre is endemic, persons without this 
condition would be statistically abnormal.
To overcome the difficulties arising from the 
misinterpretation of the word ■'normal' in medicine the term 
'reference range* was introduced by Gr&ebeck and Saris (19b9). 
This was later accepted by the Scandinavian Society for 
Clinical Chemists and Clinical Physiologists Commission on 
Reference Values, and in 1970 was also accepted by the 
International Federation of Clinical Chemistry Expert Panel 
on Theory of Reference Values.
The word 'normal* however is deeply entrenched in the 
minds of clinicians and it is unrealistic to expect them to
change to the word reference, which without qualifications, is 
vague and may lead to confusion. It is necessary therefore 
to discuss what is meant by the word 'normal1. If normal 
is used in the clinical sense to describe health what are 
its advantages and disadvantages? The major advantage is 
that the meaning represents an interpretation which has long 
been accepted by clinicians generally. For them it helps to 
answer the simple questions; "is this person healthy, is 
treatment required, or do I need to request further 
investigations?". However, normal ranges refer to single 
variables and health refers to the interaction of all 
biological variables within an organism. Furthermore it does 
not follow that because a patient has a certain disease that 
all biochemical parameters will be abnormal ; in practice 
relatively few of these measured parameters seem to be affected 
by a single disease. In this context the distinction between 
normal- and healthy is an important one. Individual variables 
are interpreted to be normal' or abnormal and the sum of 
these interpretations used to decide a diagnosis of health or 
disease. From the definitions given in the glossary it can be 
seen that normal' or abnormal results are objectively 
determined whereas, at the present time, the clinical 
assessment of health or disease is largely subjective and 
may be influenced by recent impressions, fashions in diagnosis 
and so on.
If different variables are standardised and reduced to give 
a multivariate normal range then in this situation normal begins 
more closely to approximate to what is understood as healthy.
The more variables used for the multivariate normal range 
the closer this approximation becomes. The relationship 
between normal and healthy requires clarification if 
normal ranges are to be used accurately. This relationship 
can be illustrated by reference to the process of disease 
identification. In order that disease can be recognised it 
is first necessary to have a clear picture of what constitutes 
health. However, since there is a certain element of pathology 
in everyone, health probably does not exist in the purest sense 
and therefore is intangible as a yardstick for the recognition 
of ill-health. It is this intangibility which led to the 
widespread use of the words normal and -abnormal in medicine. 
Traditionally the detection of disease arises from the complaint 
of a person suffering discomfort or overt physical, mental 
or social differences from the normal or bulk of the population. 
However by comparing a complainants physical, mental or social 
status with the bulk of the population a diagnosis of normal 
or abnormal is achieved, not health or disease. It has then 
to be decided whether any abnormality present is associated 
with ill-health. The translation of abnormality into health 
or ill-health is achieved through the knowledge and expertise 
of the medical practitioner. In clinical biochemistry -normal 
and abnormal results are signs which together with other 
signs, symptoms and patient history allow the physician to 
diagnose health or disease and also differentially diagnose disease. 
Consequently normal even in clinical usage still refers to 
that which is most common, which for most biochemistry tests
refers to the most healthy part of a population. Normal 
range is a specific expression and refers to a single 
variable which'cannot alone satisfy the multiplicity of 
factors which combine to produce good health. The word 
'normal1 when referring to a single variable is not 
therefore synonymous with the term "good health". A 
normal result is usually a desirable result but cannot 
on its own be interpreted in terms of health. The use of 
the term "health reference values" (Grfisbeck and Saris, 1969) 
should therefore be abandoned since the interpretation of 
results in these terms is misguided.
Mathematically the normal ranges refer to a continuous 
series of results which encompass those-most commonly found in 
a particular population. This group, in the majority of 
instances, is the most healthy part of a population and it 
is therefore not surprising that the clinicians view of a 
normal range refers to "health" rather than "most common".
There are situations however which appear to render this 
simplistic view untenable.
' In the case of plasma cholesterol, in certain populations 
the most common concentrations found are not consistent with 
health and therefore cannot be used as a health indicator.
For example, in the. Western world coronary heart disease is 
very common; in the Framingham study, Castelli (1978) 
reported that one man in four and one woman in eight over the 
age of 50 years developed coronary heart disease. As there
!
is a good correlation between this condition and a high 
plasma cholesterol concentration and as the condition is so 
prevalent it becomes necessary to search for a yardstick by 
which clinical assessment of the consequences of a given 
cholesterol value can be made. For this, a reference 
population is necessary in which atheroma and coronary 
heart disease are uncommon. Thus the normal , most 
commonly found, range of cholesterol values in the "disease- 
free" population becomes a reference range for the population 
at large but is by no means normal for them.
The interpretation of plasma uric acid results presents 
an'even more complex problem. People on a purine-rich diet, 
usually found in the more affluent sections of society, 
generally have raised plasma uric acid levels compared with 
people with a more modest intake of purines and yet they do 
not exhibit symptoms of gout or renal calculus production.
Talbott (1940, 1957) also reported that too often results 
were found outside the reference range in apparently
' ’ 1 .
healthy individuals. This makes the separation of normouricaemia 
from hyperuricaemia extremely difficult. Several attempts have 
been made to discriminate between these two groups. Statistical 
analysis provides guidelines but is not entirely satisfactory 
so that modifications to the reference range have to be made 
based on clinical experience. In the Framingham population 
survey (Hall e_t al, 1967; Rose et al, 1968) the reference 
interval was calculated from the distribution of uric acid
results and the prevalence of gouty arthritis in the 1002 
males investigated. Wyngaarden (1965) used another approach 
and looked at the physicochemical properties of uric acid and 
determined the solubility product of the monosodium urate 
species. He calculated that serum should be saturated at 
381yumol/1 so that above this level the development of gout 
and renal stones may be expected. However, he omitted to 
account for,other plasma factors which affect uric acid 
solubility, such as certain plasma proteins (Alvsaker, 1966).
The reference range for uric acid is therefore poorly defined 
and is based on statistical analysis of both a clinically 
normal population and a 'gouty1 population. The range has 
further been biassed by medical experience in dealing with 
large numbers of uric acid results. The range for uric 
acid is not a normal range since it does not discriminjate 
normal from abnormal but is a range describing clinically 
desirable plasma levels where the likelihood of uric acid, 
induced disease is small. This must therefore be considered 
a reference range.
The normal range is therefore a mathematical quantity 
based on the most commonly occurring values within the population 
which helps to answer the questions "can this person be considered 
healthy, is treatment needed, or are further investigations 
required?" As shown above cholesterol and uric acid cannot 
have normal ranges since they fail, without reference to 
other populations, to answer the questions "are these results 
consistent with good health or are they intolerably high?"
These ranges do not correspond with 'those values most
commonly found* in the population. The term 'reference 
interval* is more appropriate for these tests. Similarly, 
in the population with iodine deficiency and endemic goitre, 
the clinically acceptable physiological range for serum 
thyroxine concentrations must be considered a reference 
range since it does not satisfy the mathematical requirement 
of a normal range and it answers a different question for 
that population.
The term 'reference range' has been recommended by a 
number of workers including the ("International Federation 
of Clinical Chemistry Expert Panel on the Theory of Reference 
Values"). The reasons for this appear to result from the 
misuse and misinterpretation of the word 'normal*. For 
example Sunderman (1969) and Scadding (1967) stated they 
preferred 'reference range* since "it overcomes the circuitous 
reasoning which defines a normal person as 'free from disease* 
and then diagnoses disease from differences in measurable 
characteristics from normal individuals". However, according 
to the Concise Oxford English Dictionary (1975) 'normal* does 
not mean 'free from disease*, it means usual, regular, typical 
and conforming to standard and makes no allusion to health.
The reasoning need not therefore be-circuitous. The implicit 
assumption that a normal person is free from disease is 
false but in most situations normal people show a much higher 
probability of being healthy than abnormal people.
The* word 'ref erence is less specific than the word ’normal* 
and reference ranges may include normal ranges, abnormal ranges, 
therapeutic ranges and specific disease ranges. Since a 
reference range is no more than a set of values available 
for reference then any assumption that it describes health 
may be more misleading than the use of a normal range.
The following definition by Dybkaer (1972) of reference 
values describes exactly their derivation but fails to 
mention their use and their limitations when translated in 
terms of health and disease. 'Reference values* are "a set 
of values of a certain type of quantity, obtainable from a 
single individual or group of individuals corresponding to 
a stated description. The description must "be available if 
others are to use the ’reference values*.’*
Historically, normal ranges have developed from the 
concept of the ’average man* as expounded by the Belgian 
astronomer, teacher, philosopher and statistician, Adolphe Quetelet. 
The role of this ’homme moyen* is extensive, not only in medicine 
as an aid to the distinction of health from disease but also in 
politics to.describe general sentiments and public opinion, by 
the naturalists for the characterisation of racial groups and 
by the social scientists to ascertain rates of birth, growth 
and decay (Hankins, 1908). The normal range in medicine is 
a continuous range representing the most commonly occurring 
values in a population and is used to identify results which 
show a medically unacceptable departure from those expected in
the ’average man*. This normal or average man therefore 
provides the vehicle which through modification based on 
medical research and experience allows health as the 
inaccessible truth to be approached as closely as current 
knowledge permits.
Types of Reference Intervals
The term reference interval or range is used in this 
section because it is non-specific. Normal ranges can be 
considered a more specific form of reference range since 
they have imposed on them two restrictions. Firstly, they 
describe the bulk of any defined population and are representative 
or typical of that population and secondly, they are used to 
answer the question is this result typical of the defined 
population or does it show a medically significant divergence.
Reference intervals may be obtained in a number of ways 
but the most commonly used are: intervals determined from a
screened healthy sample; intervals determined from an 
unscreened hospital sample and specific reference intervals.
Whether any of these ranges are norma] ranges depends on 
their method of determination. If the range represents the 
bulk of the defined population and is typical or normal- 
for that group then it is more specifically a normal range.
Reference intervals for healthy people are difficult and 
expensive to establish. It is impractical and probably 
impossible to screen every individual, chemically, haematologically, 
anatomically, radiologically and histologically in order to make 
a clinical decision as to whether a person is healthy or 
otherwise. Since absolute health probably does not exist
the people used for the determination of this interval may 
represent the inadequacies of the screening programme more 
than health. These intervals cannot be regarded as normal 
since they are based upon data from a population defined by 
a screening programme and do not represent the most commonly 
occurring values for any predefined group. A further objection 
to this type of interval is that in order to screen for health 
it is necessary to have prior knowledge of what constitutes 
health. This would automatically bias the selection procedure 
to those people near to the mean of the preconceived idea of 
health, consequently reducing the reference interval and 
causing an increase in the number of results incorrectly 
thought to be consistent with ill-health.
A second method of obtaining reference intervals from 
healthy individuals is to use survival reference values. This 
is a technique by which a particular test is carried ou^ in a 
large number of patients and then a careful "follow-up” 
procedure is employed. A patient is only considered healthy 
if he survives for five years or more and results Irom those 
patients alone are used to derive the reference ranges. Again 
these intervals may not be normal ranges since in an elderly 
population, the bull: may not survive for 5 years and therefore 
the remainder cannot be considered normal . The problems 
involved with the determination of health reference values by 
this method are considerable. After 5 - 1 0  years it is most 
likely that the chemical method used in the first instance 
has been^replaced hopefully by an improved, more precise method. 
The whole programme would then have to be restarted and any
attempt made to predict the reference range could only be 
subjective. Failure to make such a prediction, however, will 
encourage clinicians to decide independently and may introduce 
inconsistencies in the interpretation of results. Other t
problems with this method are: the establishment of reference
intervals in the aged, (Gr&sbeck and Saris, 1969) and the 
application of reference values derived from a healthy 
ambulant population to a hospital patient population.
Hospitalised patients are generally older, (Gr&sbeck, 1972) 
and have a different diet than the healthy population. They 
are subject to psychic and somatic stress and their inactivity 
and supine posture lead to changes in the concentrations of 
such blood constituents as cells and protein which can fall 
by up to 20 per cent after 30 minutes in the recumbent position.
Blood donor patients are commonly used as the source of 
data for the determination of reference values, (Flynn et al, 1974). 
These are normal values for blood donor patients and reference 
values for the whole population, since until it is demonstrated 
that blood donors are representative of the whole population 
these ranges cannot be considered normal for that population.
It is unlikely, however, that significant differences exist 
between these two groups.
Unscreened hospital patients are 'also a source of data 
from which normal ranges for hospital patients can be 
calculated. These are not subject to personal bias but are 
subject to clinical bias and only represent the hospital 
population. Pryce (1960), Wootton and Pryce (1964), and 
Hoffman and Waid (1972) proposed the use of hospital patients
for the production of normal ranges, stressing that the bulk 
of the results are non-pathological and typical of the local 
population under hospital conditions. In addition the effect 
that bed rest and the hospital environment has on the measured 
biochemical parameters will be included in such ranges, and 
therefore make them more appropriate for use with hospital 
patients. However, this type of data will probably show a higher 
incidence of abnormal results than for example data from blood 
donors and therefore the determination of these ranges may 
require the use of more complicated statistical methods which 
attempt to resolve the normal and abnormal components. The 
majority of these methods wrongly assume that the shapes of all 
the components can be described by the same mathematical model, 
usually the Gaussian distribution. .
Other types of reference range may be more specifically 
applied, for instance to patients having a specific disease. 
However, as for all reference ranges they must only be applied 
to individuals who satisfy the conditions inherent in the 
reference group. This group must therefore be strictly defined. 
One such definition was coined by Williams in 1972, who described 
the most healthy state of an individual as: ”a personal sense
of maximum well-being, vigorous pursuit of occupation 
uninterrupted by ill-health, absence of detectable defects or 
effects of emotional stress as determined by clinical history, 
blood and urine chemistry, haematology, radiography, electro­
cardiography and detailed physical examination”. Such a battery 
of examinations to ascertain a healthy state would be uneconomical 
in both time and money, the criteria would be very difficult to 
achieve completely, and a preconceived notion of health for
each examination would be essential.
0*Halloran et al, (1970) suggest that the success or 
failure of methods for computing normal ranges from patients* 
test results appears to depend largely upon the population 
from which the sample is derived. They observed only slight 
differences between normal ranges derived conventionally 
and those derived from a group of out-patients. The frequency 
distributions of * healthy* subjects and in-patients were 
observed to have many similarities.
Collins (1975) recommends the use of a large sample of 
patients for determining normal ranges since.young healthy 
volunteers do not reflect the total variability inherent in 
members of a hospital population and would therefore not be 
normal for this group. .
Collen et al, (1969) stated that reference values must 
be based upon apparently healthy persons and the health of a 
person can be defined only after repeated observations over 
a long period of time. Within the National Bureau of Standards 
in the United States of America there has been established an 
Office of Standard Reference Data (Brady and Wallenstein, 1967) 
which, it is hoped, will not only supply reliable information 
for the definition of health in chemical terms, but will 
also supply standard measurements and reference values for 
specific categories of disease-.
In this thesis both selected and unselected patients are 
used for evaluating the methods of determining normal ranges. 
Both types of data are used in an attempt to determine the 
efficiency of statistical methods for identifying and excluding
the increased levels of abnormal contamination expected with 
the unselected patients. The patients comprising the selected 
group were chosen in the knowledge that the diseases from which 
they were suffering rarely affect the biochemical parameters 
under investigation. This data may therefore represent, more 
closely than any other type of data, results of the general 
population under hospital conditions.
Reporting and Interpretation of Results and Reference Values
One problem with multichannel analysis is the presentation 
of large numbers of results in a manner which is easy for the 
clinician to read and interpret. There are several ways of 
presenting results. The most common is simply to list the 
substances measured and their respective concentrations in mass, 
moles or, in the case of enzymes, activity per unit volume. 
Because of the lack of uniformity iri expressing results and 
the difficulty in selecting abnormal values from a large 
group of figures, Hoffman (1963) proposed the use of "Normal 
Quotient Values". These consisted of a single measurement 
scale which could be substituted for many of the existing 
measurement scales. The scale is based on the standard 
deviation of -normal subjects such that y = 5x/<J" + K where 
y is the normal quotient value, x is the analytical result, 
is the standard deviation of a normal population with 
respect to that assay and K is a constant which can be added 
or subtracted so that the mean, y = 100.
Hoffman in the same paper suggests a second method in 
which the normal range is replaced with an "illness likelihood
curve". In those areas of the frequency' distribution not 
contaminated with abnormal data, the illness likelihood is 
0 per cent. At the point of intersection between the abnormal 
and normal distributions the illness likelihood is 50 per cent 
and so on. A problem with this method is distinguishing both 
high abnormal and low abnormal results in a given test. A 
further difficulty arises when relating test values, for 
example sodium and potassium with bicarbonate and chloride.
Another method (Elveback, 1972) transforms results into 
"fractiles" which refer to the cumulative number fraction of 
the normal frequency distribution, e.g. plasma glucose = 4 mmol/1, 
which corresponds to the '60th percentile of the reference group. 
This has some advantages compared with the method of "Normal 
Quotient Values". Firstly, the true result is also reported 
which prevents loss of clinical information; 'secondly,
Gaussian statistics are not assumed; and thirdly, this method 
can easily be applied to several different reference subsets 
such as sex, dietary state and age, (Gr&.sbeck and Fellman, 19.68 ; 
Gr&sbeck and Saris, 1969; Gullick and Schauble, 1972). However, 
there is one disadvantage common to both this method and the 
standard deviate method of Hoffman, namely, that neither take 
into consideration the magnitude and overlap of the normal and 
abnormal distributions.
If the aim in developing normal limits is to reduce the 
"cost of errors" then the abnormal range must also be considered, 
(Murphy and Abbey, 1967). These workers considered the conceptual 
problems that surround the clinical interpretation of laboratory
tests and concluded that the conventional normal range is an 
unsatisfactory yardstick for making decisions because of the 
lack of consideration given to the relative sizes of the 
healthy and ill populations. Similar conclusions have been 
stated by Roller (1965)* Sunderman (1972) and Yantorno and 
Ratto (1974). The terms "discrimination value”, "decisive 
value" and "critical value" have been used to designate the 
intersection of the distribution curves for a diagnostic 
test. Refinements of the concept of the discrimination 
value have been proposed by several workers (Martin et al.,. 1975; 
Hall, 1967; Hems, 1969; Fagan, 1975; Katz, 1974; Vecchio, 1966; 
Werner et al., 1973) using a clinical application of Bayes* 
Theorem (Krause et al., 1975). There are six basic prerequisites 
to this approach which are:
(i) Clear-cut definition of the disease.
(ii) Distinctive point in the course of the disease v/here 
the diagnosis becomes objective.
(iii) Knowledge of the diagnostic sensitivity of the test,
i.e. the ability of the test to distinguish the disease 
amongst normals , (Remlin and Wilkerson, 1961).
(iv) Knowledge of the specificity of the test for that
particular disease, i.e. the ability of the test to 
identify negatives when screening possible positives.
(v) Knowledge of prevalence of diseases, i.e. number of
new cases per year divided by total number tested.
(vi) Knowledge of clinical costs or consequences of
misdiagnosis.
Discrimination values thus defined include so-called 
1 cut-off points*, * decision thresholds*, ‘operating position* 
(McNeil et al., 1975), or ‘point of operation* (Lusted, 1971). 
Wilson (1973) used ‘screening level* and Jungner and Jungner (1969) 
’borderline*. The principle of a decision threshold or action 
point is naive in the clinical environment since the vast 
majority of decisions are made from individual and careful 
appraisal of a variety of observations such as signs, symptoms 
and history as well as laboratory investigations.
In another method for reporting results, the total 
normal plus abnormal ranges for a particular test is 
divided into 10 equal segments. Each segment is equal to 
half the standard deviation of the normal .range and is 
called a "staten”, (Casey and Downey, 1970). Values are 
then reported as falling inside the range of a given staten 
segment. However, 5 standard deviations may not cover all 
possible values and compared with- the standard deviation 
method, this seems unnecessarily complicated without any 
obvious advantage.
A special problem exists with the interpretation of 
results from multiple biochemical testing or ’profiling*.
In the majority of tests, the normal and abnormal ranges 
overlap making the interpretation of borderline results 
difficult. In this situation some results, even from 
’healthy* people will be wrongly labelled abnormal , and 
the more tests performed in the biochemical profile the 
greater is the chance of producing falsely abnormal data,
(Healy, 1969; Reed, 1970 and Dybkaer and Grasbeck, 1973).
Schoenberg (1970) has calculated that if 5 tests are performed,
23 per cent of the population will have one or more values . 
outside the 95 per cent limits and 5 per cent will fall outside . 
the 99 per cent tolerance limits. On the M300 at the Royal 
Sussex County Hospital, Brighton eleven tests.are performed 
which according to Schoenberg gives a 40 per cent probability 
of finding one or more values outside the 95 per cent range 
and an 11 per cent probability of one or more results being 
outside the 99 per cent range. These estimates assume 
independence of all the variables. Other authors have 
commented on the presence of these unexpected 'outliers* in 
apparently healthy individuals (Sunderman 1970).
In addition to these essentially mathematical problems 
there is also confusion surrounding the description and 
interpretation of a biochemical result. It has already been 
stated that a single result cannot be accurately described in 
terms of health since even if health exists it is multifunctional.
A result may be talked of as consistent with a healthy state 
although there may be some disagreement of what constitutes 
this state. One person's sense of ''well-being" may not coincide 
with that of another person and therefore the "healthy state" 
may pertain to a sub-population whose sense of "well-being" is 
more tolerant to mild discomfort and sub-clinical disease. If 
pure health does not exist and the state of "well-being", on 
which the.definition of health relies, is inaccessible, then 
it may be advantageous to search for another mode of interpretation 
with a more solid foundation. Diseases are more tangible than 
health, they are generally well described and defined and so the
definition of health and the interpretation of results from 
this standpoint may be more robust. Health could be regarded 
as a level of pathology acceptable to a given person and 
society and a biochemical result may or may not suggest the 
presence of disease depending on current medical knowledge.
This method of data interpretation for most tests would be 
a compromise based upon the levels of false positive and false 
negative results. Problems with this method are discussed in 
the Discussion (p. 145) •
The'interpretation of health and biochemical results 
needs to be in a form which is acceptable primarily to medical 
staff, but also to laboratory staff and statisticians. To 
achieve this, a definable, robust yardstick which is also 
accessible and preferably empirical is required for the 
interpretation of results. As already discussed it seems that 
the only tangible yardstick available which fulfils' these 
criteria is the average man or the normal person and consequently, 
in the clinical laboratory, normal ranges are used. The only 
problem remaining therefore is to define the relationship
between health and normal so that the laboratory interpretation
■ !
based on normal ranges can be accurately translated into health and 
disease by the physician. A workable definition of health in 
terms of normal or average or most commonly found is therefore 
important. . Beginning with an extract from the World Health 
Organisation definition, "health is a state of physical, 
mental and social well-being" v/hich, as far as medical 
knov/ledge will allow, is personified by the average or 
normal person of a defined population free from endemic 
disease. Acceptable deviations from the "average man" before
a person is labelled abnormal are governed by medical knowledge 
and experience with the measured characteristics and this 
accounts for the different probability intervals seen in the 
calculation of some normal ranges.
Those ranges not based on the typical, normal or average 
person in a defined population can be called reference ranges 
or more meaningfully, desirability ranges. A desirable result 
would then be defined as’consistent with health according to 
current medical knowledge and experience but not necessarily 
typical or normal for the test population.
Statistical Considerations
There are two groups of methods used for the determination 
•of normal ranges.
(i) Parametric methods based on the Normal or Gaussian 
distribution;
(ii) Non-parametric methods.
Parametric Methods or non-parametric methods?
The Normal or Gaussian curve was invented by a number 
of mathematicians using different methods, but Gauss used it 
to represent the variation between different measurements of 
the same thing, using the same technique and the same 
instruments (Mainland, 1971). Hence, the Gaussian curve is 
an error or precision curve. When large collections of 
measurements of the same sample are examined divergences 
from the Gaussian curve have commonly been found (Topping, 1955) 
there is even less reason to expect biological measurements 
.on different people to conform to this curve. A symmetrical
bell-shaped curve or frequency distribution is often found but 
this need not necessarily be Gaussian. A symmetrical curve 
may have large shoulders (platykurtic), or be too slender and 
pointed at its apex (leptokurtic); the tails may be too long 
or too short, and it may have bumps which are not sampling 
errors, but are genuine polymorphisms within the population.
A Gaussian distribution is produced when all the accidental 
errors of observation are due to numerous, small, independent 
factors, equal in magnitude and with no bias in the positive 
or negative direction. However, accidental errors or the 
causes of imprecision are not always equal in magnitude. Some 
methods used in clinical chemistry have numerous steps, each 
having its own error, differing in magnitude from the next.
An operator or a method may exert a bias on the final result; 
for example, calcium has been shown to be adsorbed by some 
plastics used in the manufacture of Auto-Analyser sample cups. 
These would operate a negative bias by as much as 0.25 mmol/1 
(Hall and Whitehead, 1969)•
The Gaussian error curve is therefore most valuable as 
a mathematical model for investigating precision. Although 
Topping rejected most of his data for being non-Gaussian, the 
parametric methods may still be useful when there are only 
slight deviations from the Gaussian model.
Another theoretical disadvantage of the Gaussian 
distribution is that its tails never reach y = 0 but merely 
approach this value towards x =-oo andoo . This in the 
clinical situation is unrealistic since there are limits
to the levels a biochemical may reach in the body after which 
life must cease.
Dybkaer (1972) criticised the use of the Gaussian 
distribution saying that misleading information may result.
He stated that it is imperative that the distribution hypothesis 
is sound and suggested the use of transformation methods in 
order.to produce "useful" distributions. Unfortunately, he 
did not suggest which distributions may be most useful but 
proposed the use of non-parametric methods for the "not so 
useful" distributions.
Nyboe (1972) showed that many biological distributions 
are skewed and could not be described by a single model. He 
stated that it is theoretically better to use non-parametric 
methods rather than risk losing diagnostic information by 
assuming a Gaussian frequency distribution. Furthermore, 
it cannot be assumed that because a biological measurement was 
once shown to have a Gaussian distribution that this distribution 
holds true for the same measurement at other places and other 
times.
Healy (1974) claimed that in practice the observed 
distributions could nearly always be fitted to a Gaussian or 
log-Gaussian distribution provided that allowances were made 
for variations due to age and sex. Harris and De Mets (1972) 
maintained that no single transforming function can be 
expected to reduce all observed distributions to one conforming 
with a Gaussian distribution.
Non-parametric methods such as the percentile method, make 
no assumptions about the shape of the frequency distribution.
The principle has been studied by many workers (Thompson, 1938; 
Y/ilks, 1941 , 1942; Reed et al, 1971) and although the 
calculations are uncomplicated, the method is sensitive to 
abnormal contamination and may produce wide normal ranges.
This problem cannot be efficiently eliminated by increasing 
the data (Taylor, 1972). Data from assumed healthy subjects 
are therefore preferred, but the collection of this data has 
many problems which have already been discussed. According 
to O'Kell and Elliott (1970) another difficulty is deciding which 
percentiles are to be used for the normal range although this 
problem is not unique to non-parametric methods. The most useful 
probability interval for the normal range is governed by clinical 
knowledge and experience with that test. For example, a 95 per 
cent probability interval may be too insensitive and an unacceptable 
number of patients with a particular disease escape detection.
The interval would then be shortened to say 90 per cent, so that 
a realistic balance between the cost of too many falsely abnormal 
results and too many falsely normal results can be established.
The arbitrary use of the central 95 or 90 per cent of results for 
the normal range may be unrealistic for a further reason. Results 
indicative of a pathological state so-inetJtTve- occur only at one end 
of the normal range and therefore the abnormal results at the 
other end are meaningless in terms of health or disease.
In!clinical practice no matter which mathematical 
procedure is used for the determination of normal ranges a 
competent physician will modify his scale of normals according 
to the cost of errors of misdiagnosis (Ivlurphy and Abbey, 1967)*
These are the Type I and Type II errors (alpha and beta errors) 
of the statisticians, corresponding to false positives and false 
negatives in diagnostic tests. In fact, small errors in the 
estimation of the normal ranges resulting from the assumption 
that a distribution is Gaussian can be tolerated since final 
adjustments to a normal range should be based on information 
from physicians.
In summary, the non-parametric percentile method has the 
advantage of being free from assumptions and therefore can be 
used for any distribution. Confidence intervals can be expressed 
for each percentile (Elveback and Taylor, 1969) but these are long 
compared with those calculated for Gaussian methods on Gaussian 
distributions. This reflects the*efficiency with which each type 
of method utilises data (Flynn et al, 1974).
Those methods based on Gaussian statistics have the 
disadvantage of being restricted to Gaussian distributions but the 
advantage of utilising data more efficiently since the standard 
deviation is estimated as a smooth function of x. However, if the 
distribution is not Gaussian the mean + 2s method may not cover the 
central 95.44 per cent of values and the confidence interval and 
precision of the normal range may be unexpectedly poor.
It is important to determine the characteristics of frequency 
distributions on the basis of empirical observation and the choice of 
method should be based upon careful inspection of these distributions. 
The quoted normal ranges have functions to fulfil and .in most cases 
act as a screening device to detect pathological changes, and so the
most important consideration is not which statistical method is 
used but how well these ranges fulfil that purpose.
From the controversy surrounding the measurement of normal 
ranges emerges the clear fact that no single method is beyond 
criticism. The use of data from hospital patients has been shown 
to produce wide ranges (Elveback^et al, 1970; Curnow, 1965;
Amador and Hsi, 1969) and the statistical methods used for 
isolating and eliminating abnormal contamination are usually 
based on false assumptions. The use of selected patients, 
suffering diseases unlikely to affect the biochemical measurement 
in question, can also be criticised since these data may not 
accurately represent the normal population under hospital 
conditions. Data obtained from the normal ambulant population, 
represented by blood donors in a number of publications (Flynn 
et^  al, 1976; Roberts, 1967; and Little at al, 1974) may also 
be misleading when used for the hospital in-patient population.
In the absence of an ideal method or even a method which is 
universally agreed to be theoretically and practically more 
appropriate than other methods, it is necessary to examine those 
methods available and determine which gives the most useful results 
combined with the most theoretical advantages.
The final choice of statistical method used for determining a 
normal range must depend on the quality of data available. If for. 
ethical, reasons a test can only be used on a patient population with a 
high probability of showing abnormal results then one of the less robust 
statistical methods which attempt to resolve the normal component from 
a mixed distribution must be used. For other tests, which are 
inexpensive, relatively quick to perform and not uncomfortable
or traumatic to the patient, it is possible to collect data 
which more accurately represents the normal population and 
therefore the statistical method required can be less 
complicated and more robust.
In this thesis a number of statistical methods have been 
used in conjunction v/ith two types of data. The unselected 
data with a higher proportion of abnormal results than the 
selected data are used to assess the efficiency and usefulness 
of each method.
1.2 METHODS
Statistical Methods for Determining formal1 Ranges
General Description !
There are two types of sample population commonly used 
for determining normal ranges. The direct methods use data 
from presumed healthy individuals, usually blood donors, and 
the indirect methods use data from hospital patients,
a) Direct Methods
(i) Parametric In this thesis the parametric methods used 
are based on Gaussian statistics and the most frequently used 
statistic is the standard deviation (Appendix 1). A range of 
two standard deviations each side of the mean of a Gaussian 
distribution encompasses 95*45 per cent of that distribution, 
and this range is generally accepted as the normal range.
A parametric method for rejecting ’’outliers” which may 
produce too large a standard deviation was designed by 
Pierce (1852) and later applied by Chauvenet (Geigy, 1956) and Payne 
and Levell (1968). This rejection criterion is based on the probabilitycf 
obtaining a result k standard deviationsfrom the mean, given n.
For example when n - 6  all results are rejected which are more 
than 1.73 standard deviations from the mean and when n = 500, 
all results greater than 3«29 standard deviations from the 
mean are rejected. This type of method is open to criticism 
because for small numbers of n the variance of the sample will 
never approach the variance of the whole population since even 
truly representative results will be rejected. This rejection
process has since been simplified based.on the parametric 
assumption that not more than 1 in 370 observations should 
be more than 3 standard deviations from the mean. Recently 
the .rejection of data outside the mean + ks limits where the 
most commonly used value for k = 3, has been criticised (Healy, 1979) 
It is possible that an outlier can so inflate the estimate of 
s that its presence is not detected.
More robust methods for the rejection of outliers are 
based on order statistics. The simplest form is the estimate 
of the mean as the median and the standard deviation as a 
suitable multiple of the inter-quartile distance. Other 
estimates of the mean and standard deviation aan be obtained 
b y ’trimming* or censoring the sample. If an equal number of 
observations at each end of the distribution are omitted 
(symmetrical trimming) then the estimate of the mean is 
unbiased and has a high efficiency. The efficiency is 
approximately 1 - g/3 where g is the proportion of the sample 
omitted. If 10 per cent of observations are omitted the 
efficiency of the mean estimator is 97 per cent. In this 
situation however, the usual estimate of the standard deviation 
based on the trimmed sample will be biased downwards. To overcome 
this problem Healy (1978) adapted to trimmed samples the method 
of Downton (1966) for calculating the standard deviation of a 
complete sample using a weighted linear progression of values 
centred at zero. This estimator has a high efficiency but is 
sensitive to non-Gaussian distributions.
(ii) Non-parametric In this thesis the non-parametric method 
used is the percentile method developed by Herrera (1958) which 
permits assessment of the reliability of sample percentiles in 
terms of limits of excluded population percentages (Appendix 2).
The non-parametric rejection criterion proposed by 
Reed et al (1971) eliminates an observation if the distance 
between it and its closest neighbour is more than one third 
the range.
b) Indirect Methods
If it is assumed that the majority of data from hospital 
inpatients are non-pathological in nature then’ their use for 
the calculation of ranges required to represent the normal 
population under hospital conditions has obvious advantages.
The frequency distributions compiled from this type of 
data will however, be skewed towards the abnormal ranges and 
therefore it may be necessary to resolve the normal and 
abnormal components. In order that the normal and 
abnormal components may be identified, a priori knowledge 
of their shape must fee assumed. The shape or model on which 
calculations are most commonly based is the Gaussian distribution. 
For mixed distributions containing normal and abnormal data a’ 
number of methods use the mode as the centre of the normal 
component. These methods assume that frequency distributions 
for normal ranges are always symmetrical if not Gaussian and 
by reconstructing this distribution about the position and 
frequency of the mode the abnormal contamination can be 
eliminated. However, Pryce (1960) said that this range
described the bulk of the population and not the optimum or
ideal and this m a y  result in unrealistic normal ranges.
This statement suggests that it is not sufficient for
normal ranges to describe the bulk of the population but
must realistically describe the optimum or ideal. This
ignores the true definition of the word normal and such
ranges, if it is possible to derive them, must be more
accurately titled based on their derivation or use. In
order to estimate the value of the mode within its class
interval Arkin and Colton (1959) used the relationship:
; ■ Mode = L + fa . Cmo  --------r
(fa + fb)
where L = lower limit of modal group mo
fa = frequency of class interval above the mode
fb = frequency of class interval below the mode
C = size of class interval
This method was evaluated by Amador and Hsi (1969) and 
found to be biased by abnormal results.
Probability paper methods for resolving Gaussian components 
of a complex distribution have been used by a number of workers.
A frequency distribution is plotted based upon 10 to 15 class 
intervals (Freund, 1967) and the cumulative percentages are 
then calculated (Appendix 3) and also plotted on linear graph 
paper. If the data has a Gaussian distribution a sigmoidal 
curve is obtained, called an ogive which, if plotted on Gaussian 
probability paper (Hazen, 1914) produces a straight line (Curnow 
and Sheard, 1963).
The normal range is then read from the plot as 2.5th 
and 97.5th percentiles, or calculated from the mean + 2  
standard deviations. Berkson (1957) added a Gaussian deviate 
scale on the right-side ordinate for direct observation of 
the standard deviations. If the line on probability paper 
is not straight then it is assumed that the data consists 
of more than one Gaussian component which need to be resolved.
The most simple resolution methods are those of Hoffman (1963) 
and V/aid (1964). Hoffman proposed the use of a straight line 
through as many points as possible, giving greatest weight 
to those points about the 50 per cent median since they are 
more precise and less likely to be affected by abnormal 
values. This line is extrapolated to the 5th and 95th 
percentiles which are used as the limits of the normal 
range. Waid, for his normal limits, used the two points 
on probability paper at which the straight line of Hoffman 
deviates from the working line joining all points. However, 
when a distribution markedly departs from the Gaussian model, 
the working line is curved and the straight line of Hoffman 
would then be a tangent to this curve at the 50 per cent 
median. Neither the line of Hoffman nor the heavily truncated 
distribution described by the limits of Waid would accurately 
represent the bulk of the population and therefore these ranges 
could not be considered normal, (Curnow and Cook, 1964).
Hald (1952) suggested dissecting mixed frequency 
distributions by fitting a parabolic curve to the logarithmic 
form of the equation for a Gaussian distribution. The arithmetic 
is very cumbersome and the technique useful when only one
side of the distribution is affected by abnormal results.
Neumann (1968) truncated a mixed distribution at the 
limits of the straight line component and then reconstructed 
the normal component based on the total number of observations 
(Nf) in the truncated part. The selection of the truncation 
limits however, is arbitrary and leads to inconsistent results.
The method of Harding (1949) for resolving polymodal 
distributions is similar to Neumann’s method. It consists of 
dissecting a distribution at points of inflexion on probability 
paper and then restoring each truncated component to a complete 
distribution. The method of Harding which is evaluated in this 
work has been modified by the author in order to validate the 
dissection process. The Chi-Square test of 
"Goodness of Fit" is used to test the sum of the resolved 
components against the original distribution so that distortions 
produced in the resolution process may be detected (Appendix 6).
A different method for the'calculation of the cumulative 
percentages has been used by Lowe (1974). It is called the 
cyclic cumulation (Appendix 4) and has two advantages over 
the simple cumulative percentages. Firstly, a 100 per cent 
probability for a sample is never achieved with the cyclic 
cumulation and secondly, it is therefore possible to plot all 
the points of a distribution on the probability paper.
The use of Probits is an alternative to the use of 
probability paper but these are not considered here. A probit 
is based on the Normal Equivalent Deviation (N.E.D.) of 
Gaddum described in the book by Finney (1952), and is a 
mathematical conversion of a Gaussian distribution into 
a straight line (Henry and Dryer, 1965).
The efficiency with which Gaussian statistics utilise
j
data, compared with non-parametric techniques^ make these methods 
very attractive. If the problems associated with the use of 
Gaussian statistics or non-Gaussian distributions could be 
minimised then the resulting method should be extremely 
powerful. The transformation methods provide a simple tool 
for this purpose and in this thesis log transformations have 
been used (Appendix 5) • The transformed values (x ) were
1
calculated and the cumulative percentages plotted against x , 
on probability paper. If these points approximated to a , 
straight line then the distribution was taken to be log-Gaussian 
and the 2.5th and 97.5th percentiles read from the line and used 
for the limits of the normal range.
Becktel (1970) proposed a method (Appendix 7) for use 
with frequency distributions which have abnormal data only 
on one side of the mean. Using a laborious technique of 
determining the mean, the standard deviation'was then calculated 
using a technique designed by Mosteller (1946) whereby an 
unbiased estimate is achieved from the relationships expected 
in a set of chosen percentiles or linear order statistics.
Bhattacharya (1967) described another method for 
resolving Gaussian distributions from polymodal distributions. 
The differences between the logarithmic conversions of the 
frequencies of adjacent class intervals are plotted on 
ordinary graph paper and the Gaussian components identified as 
those points joined by straight lines of negative slope. The 
variance of each component is then calculated as a function of 
the slope of the lines (Appendix 8).
Cichinelli (1963) formulated a computer program for the 
separation of overlapping Gaussian distributions. The program 
uses a maximum likelihood analysis based on parametric statistics 
and will assign individuals to specific distributions.
Evaluation of Methods for Determining 'Normal1 Ranges
Direct and indirect methods of determining normal ranges 
were evaluated in the present study. The data were obtained from 
both'hospital inpatients and outpatients. The selected patients, 
with a high probability of being normal for the biochemical 
investigations listed below, were admitted to hospital for a 
variety of reasons, such as dental problems, circumcision, 
varicose ulcers, bronchitis, asthma, pre-operative appendicitis, 
pilonidal sinus, inguinal herniae, pneumothorax, vasectomy and 
haemorrhoidectomy. In those cases where patients were admitted 
for operation, only pre-operative data were used since some 
enzymes and inorganic ions are affected by anaesthetics and 
muscle relaxants. The patients used in the direct methods were 
selected before any chemical analysis of their plasma took 
place so that personal bias was minimised.
The second group of unselected data included the results 
from all patients except those from post-operative and renal 
dialysis patients. Both selected and unselected sets of data 
were tested for differences in their age and sex distributions 
using the Student*s t test. At the 5 per cent level of 
significance there was no difference between the two sets 
for either variable.
.The chemistry methods used in this study were those
performed daily on the Vickers M300 multichannel analyser.
These included: bilirubin, alkaline phosphatase, lactate
dehydrogenase (LD), total protein, albumin, aspartate 
aminotransferase (AST), calcium, phosphate, sodium, 
potassium and urea.
The statistical methods evaluated are listed in four
groups. Group A consists of direct simple methods, group B
consists of the simple probability paper methods, group C 
uses the transformation method and group D includes relatively 
more complex indirect methods for resolving Gaussian components. 
Group A
Mean + 2 standard deviations (Appendix 1.)
Percentiles 2.5 and 97.5 (Appendix 2)
Group B
(a) after cyclic cumulation (Appendix 4)
(b) after simple cumulation (Appendix 3)
(i) Percentiles (Appendix 3)
(ii) Method of Waid (Appendix 3)
(iii) Method of Hoffman (Appendix 3)
(iv) Standard Deviations s^  and s^ (Appendix 3)
Group C
Log-Transformation method (Appendix 5)
Group D
Method of Bhattacharya (Appendix 8)
Method of Becktel (Appendix 7)
Method of Harding using percentile estimates and points 
of intersection (Appendix 6)
Normal ranges were calculated for all the listed 
statistical methods using both the selected and unselected 
patients* data. Prom the results it was possible to observe 
the effects of different distributions and proportions of 
abnormal contamination on the estimates of normal ranges.
The estimates for the normal ranges have to be compared 
with those ranges currently in use since there needs to be 
some yardstick by which the different statistical methods 
can be evaluated. Furthermore, biochemical parameters used 
in this work are amongst the most commonly requested tests in 
hospital biochemistry laboratories and therefore a great deal 
of experience and knowledge of the use and interpretation of 
these test results has been accumulated. For example, in 
this laboratory alone, each of these parameters is analysed 
on average more than 50,000 times per year and each of these 
results is checked manually before' despatch to the clinician. 
The application of this experience to the evaluation of 
different statistical methods for the determination of 
normal ranges will help solve an increasing problem seen 
with certain other laboratory tests. There is a great deal 
of confusing literature describing statistical methods which 
can be used to resolve normal and abnormal components 
from a mixed distribution. Expensive, sophisticated tests, 
where for financial or ethical reasons the only data available 
is from patients with a relatively high probability of showing 
abnormal results require such a resolution process so that 
meaningful normal ranges, free of abnormal contamination 
can be calculated. However, before recommending the use of
these usually more complex, less robust methods for resolving 
normal and abnormal components, the effects of different 
levels of abnormal contamination on the simple, commonly 
used methods are determined. I
The Precision of Selected Statistical Methods for Determining 
•Normal* Ranges
After determining the normal ranges of eleven different 
biochemical analyses using both kinds of data it was possible 
to identify those statistical methods which merited further 
investigations. The precision of these, methods was then 
determined using 20 different urea frequency distributions 
each compiled from the results of a single days1 analyses. ■ '  
Approximately 100 results were used in each distribution 
and the normal ranges calculated by five statistical methods.
From each of the 20 means, lower and upper limits of normal , 
the overall means and standard deviations were calculated.
The urea results were chosen for these experiments 
for two reasons. Firstly, the precision of this method 
on the Vickers M300 is good and representative of the other 
10 methods. Table 1.1 shows the between-batch variation for 
each biochemical test performed on the Vickers M300 during 
the three years from 1973 - 1976. Mean within-batch 
variations for these tests are also presented in Table 1.2.
Secondly, the urea results contain a relatively large number 
of abnormal results at the right or high side of the 
frequency distribution and a small number of abnormal
data at the left or low side. Therefore, the efficiency of
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each of the chosen methods for dealing with both large and 
small degrees of contamination should be shown.•
1.3 RESULTS
Normal Ranges determined by all Statistical Methods
The estimated normal ranges for each statistical method 
using both selected and unselected data are shown in Tables 1.3 
to 1.13 inclusive. The frequency distributions are plotted as 
percentage frequencies to allow direct comparison between the 
selected and unselected data sets (Pigs 1.2 to 1.12 inclusive). 
To aid discussion the statistical methods have been grouped 
into four categories. Group A includes the most common, simple 
methods; Group B the simple methods requiring probability paper 
Group C using the transformed variable x 1 and Group D, methods 
which resolve the distributions into normal and abnormal 
components prior to the determination of the normal limits.
These data were collected over three years and some 
results were reported, in units which do not conform with the 
convention known as Systeme International (S.I.). These 
results have been converted to conform with this system and 
therefore some of the results may be multiples of a constant, 
that is, the conversion factor from old to S.I. units.
Bilirubin The Group A methods all produced similar normal 
limits except for the percentile method when used with 
unselected data. The percentile method v/as greatly influenced 
by abnormal results and produced a v/ider normal range than 
the other method. The mean normal range for these methods 
was estimated to be between 3.4 ^ imol/1 and 18.8 iimol/1.
Group B methods showed little difference between the 
simple cumulation percentage results and the cyclic cumulation 
percentage results. There was also little difference between 
results from selected and unselected data. The greatest 
difference between the two types of data was seen with the 
percentile method which again reflects its sensitivity to 
the presence of abnormal data.
The method of Waid produced narrow normal- ranges 
especially v/ith the unselected data. This method appeared 
to be sensitive to small changes in the shape of the frequency 
distributions. The greater the deviation of the frequency 
distribution from a Gaussian distribution the narrower were 
Waid's estimates of the normal range.
The Group B standard deviation s^  and s2 estimates of
*
the normal ranges were all similar, the mean estimates 
being 1.6 ^ umol/1 to 17.1 yumol/1.
The Group C. transformation methods gave consistent results 
for both types of data, the resolved limits being similar to 
those presently in use.
The Group D methods unexpectedly produced wider ranges 
with the selected data than with the unselected data. This 
may have been due to the influence of abnormal results as 
shown in Pig 1.1.The mean estimates of the normal limits 
for this group were 3.4^umol/l and 15«4^imol/l.
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Fig 1.1 The Effect of a Large Abnormal Component 
on the Estimates of Normal Limits _____
Normal Component
Aohnrmal Component
iConcentration 
{— “ Resolved Normal Limits
Selected Data Limits
Table 1.3 Bilirubin - Estimates of Normal Limits
Statistical Methods
Group A Methods
Mean + 2 Standard Deviations
2.5 and 97*5 Percentiles
Group B Methods
Probability Paper
a) Cyclic Cumulation 
' Percentiles
Waid* s Method 
Hoffman’s Method 
Standard Deviations
si
S2
b) Simple Cumulation 
Percentiles 
Waid*s Method 
Hoffman’s Method 
Standard Deviations
si
s2
Group C Transformation Method
2.5, 97«5 Percentiles
Group D Methods
Bhattacharya
Becktel
Harding
a) Percentiles
b) Points of Intersection
Data
Selected Unselected
- 19 jmol/1 2-19 /xmol/1
- 19 m 3 - 2 4  ”
-  21 it 'i'
CVJ1l/\ tt
- 1 7 ti ■' 7 - 1 2 tt
-  17 tt 5 - 1 5 «
- 1 7  ” 3 - 17 "
-19 ” o - 1 9  "
-  19 tt 5 -  24- tt
-  15 tt 7 -  12 tt
-  15 tt 3 -  15 tt
-  17 tt 2 -  15 tt
-  17 tt 2 -  17 tt
log X log X
-  19 tt 4 -  17 tt
-  17 tt 5 -  15 tt
-  17 tt 5 -  14 tt
-  15 tt 3 -  14 tt
-  17 tt 3 -  15 tt
3
5
5
9
3
3
2
3
7
3
2
2
4
2
3
5
2
Alkaline Phosphatase Compared with published normal range 
estimates, both group A methods overestimated the upper 
limit of normal by more than 30 per cent. This severe 
overestimation caused by the skew of the distribution to 
the right (Fig1.4) affected the percentile method more than 
the mean + 2 standard deviation method. The mean normal 
limits for this group were 21 U/l and 149 U/l.
The group B methods showed a wide range of normal 
limits. In most cases there was little difference between the 
results calculated from the cyclic cumulation percentages and 
those calculated from the simple cumulation percentages. There 
was, also little difference between the normal limits from the 
selected and unselected data. As with bilirubin, the methods 
of Waid and Hoffman produced the greatest inconsistencies in 
results from the two types of data. This was possibly because 
both methods require a linear set of points about the 50th 
percentile. When the cumulative plot was a curve then the best 
straight line was a tangent to the curve and this resulted in 
an extremely narrow normal range for the method of Waid.
The slope and position of this line determines Hoffman's 
limits and the more points used for the construction of the 
line the better would be the precision of the estimates of 
the normal range.
The group B standard deviations s^ and s^ limits gave 
consistent results with the selected data. The upper limit 
of normal was slightly lower than with the unselected data. 
Although $he lower limit of normal is shown as 0 for four of
these ranges, the true lower limit was in fact negative. This 
impossible situation exposes the method to severe criticism.
The group C method linearised the plot on probability 
paper but was heavily biassed by the abnormal data of the 
unselected distribution producing a high upper limit of 
normal . The selected data produced a more useful normal 
range.
The group D methods produced different limits which were 
all lower than the methods in groups A, B and C. The mean 
normal limits obtained with the group D methods were 
identical to the published normals , i.e. 21 - 92 U/l. The 
right-sided skew of this frequency distribution did not affect 
the group D methods as much as the other methods.
Lactate Dehydrogenase As with both the bilirubin and alkaline 
phosphatase distributions the group A methods appeared to 
overestimate the upper limit of. normal compared with other 
methods. The mean + 2 standard deviations was again the best 
method in group A.
. Group B methods produced diverse results. The method of 
Waid seriously under-estimated the limits whilst the percentile 
methods overestimated. The method of Hoffman and the standard 
deviation methods s^  and s^, when used with selected data, 
produced ranges similar to those presently in use. In groups 
A and B the selected data produced lower upper limits of normal 
than the unselected data.
The group C method produced consistent and realistic 
results for the selected data. The transformed unselected
Pig 1.2 Frequency Distributions for Bilirubin 
22 .
20
elected Data 
= 1102
18
Unselected Data 
N = 457
12•H
I 10
cr
+>
[ 10 12 
umol/1
Pig 1.3 Frequency Distributions for Alkaline Phosphatase
10
Selected Data 
N = 716
Unselected Data 
N = 1074
cr
70 80
u/i
Table 1.4 Alkaline Phosphatase - Estimates of Normal Limita
Statistical Methods
Group A Methods
Mean + 2 Standard Deviations
2.5 and 97*5 Percentiles
Group B Methods
Probability Paper
a) Cyclic Cumulation 
Percentiles 
Waid* s Method 
Hoffman*s Method 
Standard Deviations
si
S2
b) Simple Cumulation 
Percentiles 
Waid*s Method 
Hoffman*s Method 
Standard Deviations
si
s2 ;
Group C Transformation Method
2.5, 97.5 Percentiles
Group D Methods
Bhattacharya
Becktel
Harding
a) Percentiles
b) Points of Intersection
Data
Selected Unselected
0 - 135 U/l 14 - 135 U/l
28 - 163 ” 28 - 156 ’•
28 -  163 " 36 -  156 »*
50 -  85 '* 57 -  107 11
7 -  107 *' 21 -  121 "
7 -  1 1 4 "  2 1 - 1 1 4  ”
0 - 1 2 8  ’» 7 -  135 "
28 -  163 '* 28 -  156 *'
43 -  78 *' 43 -  78 »*
14 -  99 " 28 -  107 '»
O ' -  107 ** 7 -  121 "
0 -  128 ” 0 -  128 "
log x log x
25 -  120 11 28 -  142 "
7 -  99 " 28 -  85 ”
21 -  78 ’* 28 -  92 »»
21 -  78 ** 21 -  107 **
21 -  114 " 21 -  114 **
data however, did not produce a good straight line Gaussian 
distribution on probability paper. Using a Mtrial and error” 
procedure the distribution could be linearised using a 
log (x - 50) transformation.
In group D, realistic results were again obtained with 
the possible exception of Harding’s method using the selected 
data, which produced a comparatively low upper limit of normal .
Aspartate Aminotransferase This distribution appeared slightly 
skewed and presented similar problems to the alkaline phosphatase 
distributions. The group A methods produced high upper limits 
of normal while the group D methods produced‘low upper limits 
of normal • The methods of V/aid and Hoffman produced more 
narrow normal ranges than the other methods in group B.
The transformation methods produced reasonable normal 
ranges, the upper limit of normal- tending to be higher than 
with most methods.
In groups A and B .the methods produced lower upper limits 
of normal with the selected data than with the unselected 
data.. This difference was again more noticeable with the 
percentile methods than with the parametric methods.
Total Protein These results showed that in order to estimate 
the normal limits of total proteins it is essential to use 
either selected data or a method which resolves the normal 
and abnormal components. When both types of data were used 
consistent results were obtained only with Harding's method; 
all other methods except those of V7aid and Hoffman produced 
unacceptably low, lower limits of normal with unselected data.
Fig 1*4 Frequency Distributions for Lactate Dehydrogenase
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Fig 1. Frequency Distributions for Aspartate Aminotransfer:
Selected Data 
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Table 1.5 Lactate Dehydrogenase - Estimates of Normal Limits
Statistical Methods
Group A Methods
Mean + 2 Standard Deviations
2.5 and 97.5 Percentiles
Group B Methods
Probability Paper after
a) Cyclic Cumulation 
Percentiles 
Waid*s Method 
Hoffman* s Method 
Standard Deviations
si
S2
b) Simple Cumulation 
Percentiles 
Waid*s Method 
Hoffman'-s Method 
Standard Deviations
n
s2
Group C Transformation Method
2.5» 97.5 Percentiles
Group D Methods
Bhattacharya
Becktel
Harding
a) Percentiles
b) Points of Intersection
Data
Selected Unselected
61 - 193 U/l 69 - 205 U/l
72 -  201 " 81 -  215 11
75 -  208 "■ 83 -  220 "
58 -  133 ” 80 -  130 "
82 -  162 " 92 -  171 "
59 -  185 " 69 -  193 "
5 5 - 1 8 9  " 61 -  201 "
73 -  203 " 80 -  215 ”
93 -  143 " 100 -  140 "
72 -  166 ■" 80 -  173 "
56 -  178 " 61 -  189 ”
50 -  183 " 58 -  192 "
log x log (x - 50)
70 -  198 " 84 -  195 ”
61 -  185 " 76 -  166 "
72 -  155 w 81 -  169 ,f
70 -  146 " 75 -  175 ”
6 3 - 1 5 6  " 70 -  180 "
Table 1.6 Aspartate Aminotransferase - Estimates of Normal .Limits
Statistical Methods
Group A Methods
Mean + 2  Standard Deviations
2.5 and 97.5 Percentiles
Group B Methods
Probability Paper after
a) Cyclic Cumulation 
Percentiles 
Waid’s Method 
Hoffman*s Method 
Standard Deviations
si
S2
b) Simple Cumulation 
Percentiles 
Waid*s Method 
Hoffman’s Method 
Standard Deviations
si
s2
Group C Transformation Method
2.5f 97.5 Percentiles
Group D Methods
Bhattacharya
Becktel
Harding
a) Percentiles
b) Points of Intersection
Data
Selected Unselected
2 - 15 U/l 2 - 1 6  U/l
3 - 15. *’ 4 - 18 »»
3 -  16 ” 4 - 1 8  "
2 - 9  ” 5 - 9  **
4 -  12 ” 4 - 1 2  **
2 - 1 4  ” 2 -  15 **
1 - 1 4  ** 2 -  15 *’
3 -  15 ** 4 -  17 *'
3 - 10 . « 5- 8  **
4-12 ’» 4 - 12 *’
1 -  14 ’* 1 -  15 *'
1 -  14 ** 1 - 1 5  ”
log X log X
4 - 1 7  ’* 4 - 1 7  «
3-12 '» 5-10 "
3 - 1 1  *' 4 - 9  **
3 - 1 0  " 3 - 1 3  "
2 - 1 1  ” 3 - 1 4  "
Albumin Other than the method of Waid after cyclic cumulation 
all the methods produced similar upper limits of normal .
The lower limit of normal however, which is affected by 
abnormal results, produced lower results with the unselected 
data than with the selected data. The method of Hoffman and 
the group D methods gave clinically useful estimates with the 
unselected data.
Calcium The estimates of the upper limits by all methods and 
using both types of data were similar. The percentile methods 
again produced the widest normal- ranges whilst the parametric 
methods appeared not to be so influenced by abnormal data.
The group D methods produced realistic ranges with both types 
of data but the selected data produced the most consistent ranges.
Phosphate The unselected data unexpectedly produced more 
narrow normal ranges than the selected data. The number of 
abnormal results for this method appeared to be comparatively 
small and the distributions were consistently symmetrical.
Because of this symmetry most of the methods produced very 
similar normal limits except for the method of Waid. The 
probability paper plot was reasonably linear without using a 
transformed value of x.
Sodium The greatest difference between the two types of data 
was at the lower limit of normal where the bulk of abnormal- 
data is found. The group D methods and Hoffman’s method using 
unselected data produced normal ranges similar to the group A 
methods using selected data. The estimated normal range 
was 133 mmol/1 to 143 mmol/1.
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Fig 1*6 Frequency Distributions for Total Protein
Selected Data
N = 1139
Unselected Data 
N = 78810
6860 80 88
g/1
1*7 Frequency Distributions for Albumin
12
Selected Data 
F = 1102 
Unselected Data
11
10
9
8
7
6
4
3
2
26 28 30 32 34 36 38 40 42 44 46 48 30 52
g/1
Table 1.7 Total Protein - Estimates of Normal Limits
Statistical Methods
Group A Methods
Mean + 2 Standard Deviations
2.5 and 97*5 Percentiles
Group B Methods
Probability paper after
a) Cyclic Cumulation 
Percentiles 
Waid’s Method 
Hoffman’s Method 
Standard Deviations
si
S2
b) Simple Cumulation 
Percentiles 
Waid’s Method 
Hoffman’s Method 
..Standard Deviations
s
1
s2
Group C Transformation Method
2.5, 97.5 Percentiles
Group D Methods
Bhattacharya
Becktel
Harding
a) Percentiles
b) Points of Intersection
Data
Selected Unselected
61 - 84 g/1 53 - 83 g/1
62 -  82 ”  51 -  80 ’ ’
60 -  83 ” 51 -  81 ”
63 -  82 ” 68 -  86 ”
63 -  82 ” 59 -  79 «
61 -  85 ” 55 -  83 ”
61 -  85 " 54 -  84 "
59 -  82 ” 51 -  80 ”
60 -  '86 ” 64 -  84 "
61. -  80 ” 57 -  78 ”
61 -  82 ” 54 -  82 "
60 -  83 ” 53 -  83 ”
log (100 - x) log (100 - x) 
59 -  81 ’’ 52 -  79 ’’
61 -  86 " 5 7 - 8 1  ”
65 -  83 ” 58 -  82 ”
59 -  82 ” 60 -  80 ’’
62 -  86 »» 64 -  84 ”
Table 1.8
i
Statistical Methods
Group A Methods
Mean + 2 Standard Deviations
2.5 and 97-5 Percentiles
Group B Methods
Probability Paper after
a) Cyclic Cumulation 
Percentiles 
Waid's Method 
Hoffman's Method 
Standard Deviations
8i
S2 '
b) Simple Cumulation 
Percentiles 
Waid's Method 
Hoffman's Method 
Standard Deviations
si
S2
Group C Transformation Method
2.5* 97.5 Percentiles
Group D Methods
Bhattacharya
Becktel
Harding
a) Percentiles
b) Points of Intersection
Selected Unselected
34 - 50 g/1 28 - 50 g/1
3 1 - 4 8  " 27 - 47 ''
32 - 4 9  " 28 -  47 "
39 -  49 " 37 -  43 "
36 -  48 '» 32 -  48 "
37 -  48 " 29 -  51 "
34 -  51 ” 29 -  51 "
31 -  48 " 2 6 - 4 7  "
38 -  51 " 38 -  49 "
36 -  47 ” 34 -  46 *'
34 -  49 " 3 0 - 5 0  "
33 -  49 " 30 -  50 •'
log (50 - x) log (50 - x)
35 -  47 " 24 -  46 '»
36 -  52 " 33 -  48 "
33 -  50 " 34 -  48 '»
3 5 - 4 8  " 36 -  47 "
35 -  51 ” 38 -  51 »'
Albumin - Estimates of Formal Ranges
Data
1*8 Frequency Distributions for Calcium
Selected Data 
N » 1093 
Unselected Data 
N «* 661
12
/—
_/
1.75 2.15 2.35 2.55 2.75
mmol/l
Figo 1o9 Frequency Distributions for Inorganic
Phosphate
7 -Selected Data 
N= 1124
•Dnselected Data 
N * 1466
6
Vt5
1
0.74 1.261.00 1.52
mmol/l
Table 1.9 Calcium —  Estimates of Normal Limits
Statistical Methods
Group A Methods
Mean + 2 Standard Deviations
2.5 and 97.5 Percentiles
Group B Methods
Probability Paper after
a) Cyclic Cumulation 
Percentiles 
Waid’s Method 
Hoffman* s Method 
Standard Deviations
8i
s2
b) Simple Cumulation 
Percentiles 
Waid*s Method 
Hoffman’s Method 
Standard Deviations
si
Data
Selected Unselected
2.18 - 2.65 mmol/l 2.03 - 2.53 mmol/l
2.13 - 2.60
2.15 - 2.63 
2.33 -  2.68 
2.25 -  2.60
2.20 - 2.65
2.15 - 2.73
2.13 - 2.60 
2,28 - 2.73 
2.23 - 2.58
2.18 - 2.63
2.15 - 2.63
Group C Transformation Method log;(5-x)
2.5 - 97.5 Percentiles
Group D Methods
Bhattacharya
Becktel
Harding
a) Percentiles
2.17 - 2.60
2.20 -  2.63
2.23 - 2.65
2.23 -  2.60
1.95 - 2.65
b) Points of Intersection 2.20 - 2.73
1.95 - . 2.68 
2.20 -  2.65
2 .13  -  2 .63
2 .0 5  -  2 .70
2 .00  -  2 .75
1 . 9 5 - 2 . 6 5  
2 .20  -  2.50  
2 .10  -  2.60
2.03 -  2.68
2 .0 0  -  2 .70  
log (5-x) 
2 .03  -  2 .63
2 . 1 3  -  2 . 6 8  
2 .15  -  2 .65
2.05 -  2.60 
2 .08  -  2 .70
Table 1.10 Phosphorus - Estimates of Normal Limits *
Statistical Methods
Group A Methods
Mean.+ 2 Standard Deviations
2.5 and 97.5 Percentiles
Group B Methods
Probability Paper after
a) Cyclic Cumulation 
Percentiles 
Waid*s Method 
Hoffman*s Method 
Standard Deviations
8i .
s2
b) Simple Cumulation 
Percentiles 
Waid*s Method 
Hoffman* s Method 
Standard Deviations
si
S2
Group C Transformation Method
Group D Methods 
Bhattacharya 
Becktel 
Harding
a) Percentiles
b) Points of Intersection
Data
Selected Unselected
0.61 - 1.52 mmol/l 0.58 - 1.42 
0.61 - 1.55 " 0.58 - 1.45
0.65 - 1.58 *' 0.58 - 1.45
0.42 - 1.26 *’ 0.58 - 1.36
0.71 - 1.39 " 0.65 - 1.36
0.54 - 1.52 ’• 0.54 - 1.42
0.54 - 1.52 ’* 0.54 - 1.42
0.61 - 1.55 " 0.58 - 1.45
0.42 - 1.26 ** 0.54 - 1.26
0.68 - 1.36 »» 0.65 - 1.32
0.61 - 1.42 " 0.58 - 1.39
0.54 - 1.49 " 0.54 - 1.42
Unnecessary
0.61 - 1.45 " 0.61 - 1.36
0.65 - 1.42 *' 0.58 - 1.36
0.61 - 1.36 *• 0.61 - 1.32
0.48 - 1.42 ** 0.54 - 1.45
mmol/l
»»
it
it
tt
tt
ti
«
it
ti
it
ti
ti
n
n
it
Potassium Like the phosphates, this distribution was 
symmetrical and appeared to contain few abnormal results.
Hence, most statistical methods produced similar normal- 
limits, 3.2 and 4.8 mmol/l. Transformation methods were 
unnecessary.
Urea There'appeared to be a larger proportion of abnormal- 
results for urea than any other test assayed on the Vickers M300. 
The urea frequency distributions therefore provided a difficult 
test of the efficiency of each statistical method. The estimates 
of the lower limit of normal were widely scattered, possibly 
because the parametric methods allow abnormal results at one 
end of the frequency distribution to influence those at the other 
end.
The estimates of the upper limit of normal were also 
widely dispersed ranging from 6.5 mraol/1 to 11.8 mmol/l. The
2.5 and 97.5 percentile methods produced the highest upper 
limit of normal whilst the 5 and 95 percentile limits of 
Hoffman and the group D methods produced results comparable 
with the normal limits currently in use. The method cf 
Waid appeared erratic and produced the most narrow normal 
limits. The selected data produced more narrow ranges than 
the unselected data. The transformation method used with 
the selected data produced results consistent with those 
limits currently in use. The normal limits of the methods 
of Hoffman and the group D methods were 2.0 mmol/l and 7.8 mmol/l.
Pig. 1.10 Frequency Distributions for Sodium
Selected Data 
N = 1104
Unselected Data 
N * 785 I
A
125 129 133 137 141 145
mmol/l
Frequency Distributions for Potassium
-— Selected Data 
N « 1098
. Unselected Data, 
“ N * 1134 i
4 .6 5.0
Table 1.11 Sodium - Estimates of Normal Limits
Statistical Methods
Group A Methods
Mean + 2 Standard Deviations
2.5 and 97.5 Percentiles 
Group B Methods 
Probability Paper after
a) Cyclic Cumulation 
Percentiles 
Waid’s Method 
Hoffman* s Method 
Standard Deviations
8i
S2
b) Simple Cumulation 
Percentiles 
Waid’s Method 
Hoffman’s Method 
Standard Deviations
ai
S2
Group C Transformation Method
2.5 - 97*5 Percentiles 
Group D Methods 
Bhattacharya 
Becktel
Harding
a) Percentiles
b) Points of Intersection
Data
Selected Unselected
132 - 145 mmol/1 129 - 144 mmol/1 
130 - 143 " 128 - 143 ”
131 - 143 
134 - 143 
133 - 143
" 1 2 8 - 1 4 3
" 132 - 138
tt 130 - 143
132
132
130
135
133
144
145
143
145
142
” 129 - 144
" 129 - 144
" 127 - 142
133 - 139
it 130 - 142
132 - 144
131 - 144 
log (200
132 - 143
131 - 146
133 - 144
134 - 143 
134 - 146
** 129 - 144
1 129 - 143
x) Transform
" 129 - 142
" 131 - 143
" 131 - 143
" 131 - 143
" 132 - 144
Table 1.12 Potassium - Estimates of Normal Limits
Statistical Methods
Group A Methods
Mean + 2 Standard Deviations
2.5 and 97*5 Percentiles
Group B Methods
Probability Paper after
a) Cyclic Cumulation 
Percentiles 
Wald* s Method 
Hoffman1s Method 
Standard Deviations
'  si 
S2
b) Simple Cumulation 
Percentiles 
Waid*s Method 
Hoffman*s Method 
Standard Deviations
si
S2
Group C Transformation Method
Group D Methods 
Bhattacharya 
Becktel 
Harding
a) Percentile
b) Points of Intersection
Data
Selected
3.2 - 4.8 mmol/1
3.2 - 4.8 »»
3.2— 4.9 ”
3 .3  -  4 .9  ”
3 .3  -  4 .8  *»
3 .2  -  4 .9  *»
3 .2  -  4 .9  "
3.1 -  4 . 8 * ’’
3.1 -  4 .9
3.*2 -  4 .6  »*
3.1 -  4 .8  «*
3.1 -  4 . 8  **
Unnecessary
3 .5  -  4 .6  "
3 .2  -  4 .8  "
3.1 -  4 .8  "
2 .7  -  4 .3  **
Unselected 
3.1 - 5.1 mmol/1
3.0 - 5.2 *»
3.0 - 5.2 **
3.4 - 4.8 »*
3 o  - 4.9 "
3.1 - 5.1 "
3.0 - 5.2 '*
3.0 - 5.1 "
3.4 - 4.6 **
3.2 - 4.8 •*
3.0 - 5.0 ”
2.9 - 5.1 "
3.2 - 4.9 *'
3.1 - 5.0 "
3.2 - 4.7
3.5 - 5.1
Fig. 1.12 Frequency Distributions for Urea
“ Selected Data 
N=1111
- Unselected Data
» = 757
12
mmol/l
Table 1.13 Urea - Estimates of Normal Mmits
Statistical Methods
Data
Group A Methods Selected
Mean + 2 Standard Deviations 1.8 - 8.5 mmol/i
2.5 and 97*5 Percentiles 2.7 - 9-3 "
Group B Methods '
Probability Paper after 
a) Cyclic Cumulation
Percentiles 2.5 - 9*3 "
Unselected
1.5 - 10.3 mmol/1
2.5 - 11.3 "
2.5 - 11.3 "
Waid's Method 3.3 -  6 .6 tt 3 .0  - 6 .5 it
Hoffman's Method 2 .7 -  7 .5 ft 2 .7  - 8 .6 tt
Standard Deviations •
> 1 2 .0 -  8 .0
fl 1 .3  - 9 .8 it
S2 1 .5 -  8 .5
ft 1 .0  - 10 .0 tt
b) Simple Cumulation
Percentiles 2 .3 -  9 .0 ft 2 .2  - 11 .0 tt
Waid's Method 1.7 -  6 .6 fl 3 .5  - 9 .0 tt
Hoffman's Method 2 .5 -  7 .0 ft 2 .0  - 8 .6 tt
Standard Deviations
si
1 .8 -  7 .5 ft 1 .0  - 9 .6 tt
S2 1-2 -  8 . 0
It 0 .8  - 9 .8 tt
Group C Transformation Method (log x) (log x)
2 . 5  and 97 .5  Percentiles 2 .3 -  8 .3 It 2 .3  - 11 .8 tt
Group D Methods
Bhattacharya 2 .0 -  7 .6 ft 2 .0  - 8 . 5 tt
Becktel 2 .5 -  7 .3 It 2 .0  - 8 .3 tt
Harding
a) Percentiles 2.2 -  7 .0 ft 1 .8  - 7 .8 tt
b) Point's of Intersection 0 .8 -  8.1 ft 1 .5  - 8 . 0 it
Results of the Precision Experiments on Five Selected Methods
for the Determination of Normal Ranges using Urea Results
The results are shown in Table 1.14. The mean of means 
and means of normal limits are given for each sample of 100.
The overall means and standard deviations are given at the foot 
of each column. The method of Bhattacharya showed the poorest 
precision whilst the method of Harding showed the best precision, 
with Becktel1s method next. The precision of the transformation 
methods was very good for the lower limit of normal but poor 
for the upper limit where the distinction between normal and 
abnormal was most difficult. The mean estimates of the 
sample means for all five methods ranged from 4.8 to 5.4 mmol/1. 
The standard deviation for these means was highest with the 
method of Bhattacharya (0.8 mmol/1), the other methods showed 
standard deviations of the means betv/een 0.4 and O.5..
The mean estimate of the lower limits of normal ranged 
between 1.6 and 2.8 mmol/1. Only in the method of Bhattacharya 
did both the range of lower limits and the range of upper limits 
overlap with the range of sample mean values. Excluding the 
results of the method of Bhattacharya the mean lower limits 
ranged from 1.6 to 2.3 mmol/1. Excluding the transformation 
method the mean upper limits ranged from 8.1 to 8.6 mmol/1.
Thus an all age group normal range for urea based on this 
data would be between 1.9 and 8.4 mmol/1. This agrees 
very well with those normal limits obtained by the four 
methods of Hoffman, Bhattacharya, Harding and Becktel 
calculated from the unselected data in the previous section.
Table 1.14 Precision of Five Statistical Methods in the
Determination of Normal Limits of Urea Results
Method
Statistic Bhattacharya Becktel Harding Hoffman Transformation 
 __    ^ _________ _________ _________  Percentile
20
5 .4
2 .3
12 .7  
0 . 4  
0 .3
1 .5
N — - Number of Urea Distributions analysed
X = mean of the means .
xii = mean of lower limit of normal
xl2 = mean of upper limit of normal
s-
X
= standard deviation of the mean
s!
1
= standard deviation of lower limit of normal
si■12
standard deviation of upper limit of normal
N 19 20 20 20
x mmol/1 5.3 5 .4 4 .8 5 .3
il1 mmol/1 2.8 2.2 1.6 2.0
xl2 mmol/1 . 8.1 8 .5 8.6 8.6
s- mmol/1 0.8 0 .5 0 .4 0 .5
s-, mraol/l 
1
1.0 .0 .5 0.6 o:6
s-i mmol/1 1.2 0.8 0.6 1.0
2
The transformation method using selected data also agreed 
with this range but the use of unselected hospital data 
produced unrealistic upper limits with this method and is 
not to be recommended.
DISCUSSION
After using and comparing the results of some of the 
methods available for the calculation of normal ranges, it 
is apparent that there is no ideal, accurate method which 
can be applied to all test distributions. It is also 
apparent that the normal range produced by a method may 
need modification based on clinical use and experience.
It is this clinical experience which safely allows the 
normal ranges as defined in the glossary to be interpreted 
in terms of health and disease. The majority of normal 
ranges produced by the laboratory scientist are guidelines 
for clinicians to interpret single test results. Each 
clinician according to his or her specialty may modify the 
laboratory normal range according to the type of sub-population 
investigated. For example, a slightly raised AST level in a 
patient attending a rheumatology clinic may be disregarded 
but the same level found in a cardiac outpatient would be 
considered important enough for further investigation. Strict 
interpretation of results may therefore require normal- ranges 
for different groups of people, for example, a rheumatology 
outpatient group, a cardiac outpatient group, and so on.
However, this could create a potentially dangerous' situation 
since by using such groups the normal ranges may be liberalised 
towards the diseases under investigation. Allowing for natural 
physiological variables such as age and sex, the normal range 
should therefore represent the majority of the normal , or 
most commonly found people in the population. However, the
collection of data from the general population has organisational 
problems as well as, in the case of expensive, complicated and 
even dangerous tests, ethical problems. Furthermore, there is 
so much data routinely produced by hospital laboratories that 
the bulk probably lie within the normal ranges for the general 
population. The problem with these routine hospital data is 
distinguishing normal- from abnormal and eliminating the 
effect of the latter on the estimates of the normal range.
To determine whether this is possible the statistical methods 
used for the calculation of these ranges have been evaluated 
in terms of their ability to cope with abnormal contamination 
in'a frequency distribution. The initial investigation in this 
work used two types of data, selected and unselected, in an 
attempt to assess the effect of abnormal data on the more 
simple methods for the calculation of normal ranges.
During the 4 years prior to the collection of these data 
all results were manually inspected before release to the wards.
This corresponds to the inspection of more than 200,000 reports 
on each test from which a considerable amount of experience 
was gained concerning the effects of the more common diseases 
on these tests. It was apparent that each pathological, process did not 
affect all biochemical pathways and parameters since, if this 
was the case, biochemical differentiation of disease would be 
impossible. Furthermore, the size and complexity of the 
biochemical pathways in the body and the large number of 
biochemicals involved makes it unlikely that any given disease 
will affect more than a relatively small part of this system. 
Exceptions to this are well described and include diabetes and
the systemic diseases. It is possible therefore to select 
patients who although suffering from an identified disease 
have a high probability of exhibiting normal values for a 
given biochemical measurement. It was this experience which 
allowed the identification and selection of those patients 
who could be used for the collection of a data base 
representing the normal population under hospital conditions.
Group A Methods
The mean + 2s method produced workable normal ranges 
with those symmetrical frequency distributions which were 
similar v/ith both selected and unselected data, namely, the 
potassium and phosphate distributions. Bilirubin, alkaline 
phosphatase, LDH and AST also produced similar ranges for 
both types of data using the mean + 2s method, however of these 
only LDH, potassium, alkaline phosphatase and phosphate showed 
similar ranges when using the percentile method on both types of 
data. Bilirubin and AST showed clinically significant differences 
between the two types of data using the percentile method. The 
four tests, therefore, alkaline phosphatase, LDH, potassium and 
phosphate showed similar ranges for the unselected and selected 
data irrespective of the type of statistical method used. Possible 
reasons for this are: a low degree of abnormal contamination with
these tests; or the unselected data may not have accurately . 
represented the total variability within the hospital population; 
or the selected data was not representative of the normal situation and 
was also contaminated with abnormal data. The second possibility
is unlikely considering the number of results in each 
distribution and the length of time used to collect this 
data. The third possibility cannot be completely overruled, 
but the patients used to collect each type of data were 
clinically different as seen with the bilirubin, AST, total 
protein, albumin, calcium, sodium and urea results. The 
first possibility of a low degree of abnormal contamination 
in the unselected group therefore seems the most likely 
explanation*
Both group A methods showed certain limitations. The 
percentile method was greatly influenced by abnormal data 
and produced wide normal ranges. The mean .+■ 2s method was 
affected to a lesser extent but could only be used for 
distributions which were not heavily skewed. ' The heavily 
skewed alkaline phosphatase distribution produced negative 
lower limits. The use of the standard deviation is more 
efficient than the percentile method and requires less data 
for the same confidence interval. The percentile method is 
simple and can be applied to any distribution no matter how 
skewed and is therefore more robust. The mean + 2s method 
however provided ranges which were clinically more useful, 
and with the one exception of the heavily skewed distribution 
is the method of choice so far.
Group B Methods
There was very little difference between those ranges 
calculated from a simple cumulative percentage and those 
from the cyclic cumulative percentage. Since a 100 per cent 
probability is never reached with the cyclic cumulation it 
has the advantage that the end points of the distribution 
can be plotted. This may be of particular value when 
dealing with small amounts of data where the tails are 
relatively more important to the plot. However, with the 
large amount of data used in this work it seems that there 
are no practical advantages to be gained from using the more 
complex cyclic cumulation.
The percentile methods in group B were used primarily to 
detect differences between the two cumulation procedures. The 
percentile estimate using the simple cumulation should be 
identical to the percentile estimates of group A. Any 
differences were due to error in plotting and reading off the 
probability plot.
The s„ estimate of the standard deviation was calculated 
from the 84.13 and 15.87 percentiles and the- s^ estimates from 
the 97.72 and 2.28 percentiles. Since the frequency density 
is greater for the s^ percentiles, the method is likely to 
be more robust than the s^ method. The s^ estimates are also 
more likely to be affected by abnormal data. The s^  estimates 
of the normal range were more narrow than the s^ estimates for 
the majority of tests but the differences were generally 
insignificant. This finding with the unsele.cted data was
surprising since it was expected that the abnormal results
would affect the s^ estimate considerably more than the s^.
Possible explanations of this are firstly, that there is
little abnormal contamination in all of the frequency
distributions or secondly, that the overlap of the normal
results by the abnormal results extends up to and possibly
beyond the 15*87 and/or 84*13 percentiles. The first
possibility is unlikely since most of the patients will
show an abnormal result for at least one of the eleven
biochemical variables. This suggests that the average
abnormal contamination for the 11 variables will be a
minimum of __1^ x 100$ = 9*09$. Tests such as AST and urea 
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have a higher incidence of abnormal results than tests 
such as total protein, albumin, phosphate and calcium and 
therefore the agreement between the s^ and s^ estimates for 
the different tests was expected to vary. The second possibility 
is the most likely, but for the s^  and s^ estimates to agree 
the abnormal contamination must represent- a proportional 
increase in frequency for both 97*72 and 84.13 percentiles 
and/or the 2.28 and 15*87 percentiles. In order to investigate 
this problem further another percentile estimate of the 
standard deviation was calculated using the percentile 
difference (69*15 - 30.85)/1. This is referred to as the 
s^ estimate. Calculation of the standard deviation from the 
central 38.30 per cent of the values in a frequency distribution 
should by excluding the majority of abnormal results allow the 
normal ranges to be determined even from unselected data.
The results given in Table 1.15 show that with all the tests the 
s^ estimates of the normal ranges have not altered significantly 
from those s^ and s^ estimates of unselected data. The use of 
different percentiles to calculate the standard deviation does 
not therefore appear to overcome the effect of abnormal 
contamination on the normal ranges as judged by comparison with 
those ranges derived from selected data. Tests such as total 
protein, albumin, calcium, sodium and urea which have a 
relatively high proportion of abnormal contamination in their 
unselected data illustrate this point better than the other 
tests. An explanation for this observation is that the 
abnormal data is eliminated only after the percentiles have 
been calculated and therefore will affect the percentile 
estimates irrespective of the relationship used for the 
calculation of the standard deviation.
There is another problem associated with the use of 
selected patients to represent the normal population under 
hospital conditions. Since those diseases least likely to 
affect given biochemical measurements are predominantly the 
less serious diseases then the average length of time of 
hospitalisation for the selected patients may be significantly 
shorter than that for the whole hospital patient population. 
Furthermore it is possible that the prolonged bed rest seen 
in the more seriously ill and chronically ill patients affects 
certain of the biochemical variables used in the M300 profile.
For example, the lower levels of total protein and albumin 
found in the unselected data may be due to an increase in 
protein catabolism associated with muscle wasting. The
Table 1.15 Normal Ranges for Selected and Unselected Data using
Different Percentile Relationships for
of the Standard Deviation
Unselected
Bilirubin
uraol/1
Alkaline phosphatase 
U/l
LDH.
U/l
AST
U/l
Total protein 
g/1
Albumin
g/1
Calcium
mmol/1
2 -  15 
2 - 1 7  
3 - 1 5
7 - 121 
0 - 128 
7 - 121
61 - 189 
58 - 192
62 - 190
1 - 1 5  
1 - 15 
1 - 14
5 4 - 8 2
53 - 83
54 - 82
30 - 50 
30 - 50 
30 - 50
2.03-2.68
2.00-2.70
2.06-2.68
Phosphate
mmol/1
0.58-1.39
0.54-1.42
0 .58-1.36
Sodium
mmol/1
Potassium
mmol/1
Urea
mmol/1
129
129
129
3.0
2.0
3.0
1 .0  
0.8 
1.2
144
143
143
5.0
5.1 
5.0
9*6
9.8
9.2
the Estimation
Selected
2 - 17 
2 - 1 7
0 - 107 
0 - 128
56 -  178 
50 - 183
1 - 14 
1 - 14
61 - 82
60 -  83
.34 - 49 
' 3 3 - 4 9
2.18-2.63
2.15-2.63
0 .61- 1.42
0.54-1.49
132 - 144 
131 - 144
3.1 - 4.8
3.1 - 4.8
1.8 - 7.5 . 
1.2 -  8.0
increased ranges for urea between selected and unselected 
patients may also be accounted for by this protein catabolism. 
In support of this Dietrick et al (1948) found bed rest 
increased nitrogen excretion which reflects on the plasma 
levels and the dietary protein intake.
Lack of sufficient sunlight for the synthesis of 
Vitamin D, coupled with a poor hospital diet may lead to a 
decrease in calcium absorption from the intestine. These, 
associated with increased calcium resorption from bone and 
increased calcium excretion will lead to a total body deficit 
and ultimately result in decreased levels of plasma calcium in 
the long-term patients. Environmental sources of variation 
such as these are poorly documented and it is possible that 
normal ranges may need modification to take into account 
the length of hospitalisation and bed-rest before they can 
-be interpreted accurately in all patients.
The method of Waid produced unrealistically narrow ranges 
based on a truncated distribution. lit assumes that all normal 
results follow a Gaussian distribution and those which deviate 
from this model are abnormal. The range is therefore a Normal 
or Gaussian range and is inappropriate as a standard for 
clinical comparisons.
The method of Hoffman produced clinically useful results 
with a number of the tests but is also based on a linear 
Gaussian subset of results closest to the median. In this 
method the straight line of the Gaussian subset is extrapolated 
on probability paper- to the 5th and 95th percentiles. With
some distributions, however, a straight line subset of 
results could not be identified and the extrapolated line 
was a tangent to the curve of the probability paper plot.
A slight error in the identification and construction of this 
line is magnified when extrapolated to the 5th arid 95th 
percentiles. The method lacked robustness and is not 
practicable with all distributions.
The use of a logarithmic transformation of values along the x axis 
to linearise the probability paper plots was very successful.
This technique did however linearise the unselected data as 
well as the selected data and was therefore of little use in 
the identification and differentiation of abnormal' and normal 
data. As a result of this some of the ranges calculated for 
the unselected data were too wide for clinical use. There 
were two distributions, potassium and phosphate, which showed 
a Gaussian distribution without logarithmic transformation 
and the limits determined for these are therefore identical 
with the limits calculated by the percentile method in group A.
Where the distributions were negatively skewed such as total 
protein and albumin, a logarithmic transform of the type, 
log(K-x), was used where K is an arbitrarily chosen constant 
of greater value than the largest value of x. For example, 
in the case of total protein a log (100 - x) transform was 
used. It has been shown (Tukey, 1957) that addition or 
subtraction of a constant from the values of x sometimes 
improves the log-Gaussian linearity on probability paper, 
however, this was not attempted since without the aid of a
computer the search for suitable constants would be too 
cumbersome. The normal ranges determined v/ith the 
selected data showed good agreement with ranges currently 
in use and the logarithmic transform method appears to be 
particularly useful for this type of uncontaminated data.
, The group D methods are more complex methods which use 
a resolution process to identify and exclude abnormal data 
from a mixed distribution.
The method of Bhattacharya uses simple but tedious 
arithmetic for the identification of Gaussian subsets within 
a distribution. Unfortunately it is not clear which or how 
many of these subsets need to be included in a normal range 
so even after a lot of arithmetic, personal judgement and 
guessv/ork is required for the final computations. Judgement 
is also required when constructing-lines of negative slope 
since not all of the points follow a straight line and some 
may have to be disregarded when they show gross deviations 
from the general trend. The precision of the method was poor 
and the range of results for both limits of the normal 
range overlapped the range of results for the mean. Most of 
the ranges calculated using unselected data were more narrow 
than those calculated from the selected data. This may have 
been poor judgement on the selection of Gaussian subsets for 
inclusion in the normal range resulting in a truncated 
distribution. The method has been shown to be unreliable 
and of little use for the determination of normal ranges 
irrespective of the type of data used.
The method of Becktel is based on a simple concept but 
it has two limitations restricting its use. Firstly, it 
assumes a symmetrical distribution for normal values and 
secondly abnormal contamination is assumed to occur only at one 
end of. the frequency distribution. Skewed distributions 
produced narrow normal ranges. The use of this method 
with a frequency distribution of results from a new test of 
which little is known would therefore be hazardous and cannot 
be recommended.
The method of Harding is more complicated and involves 
a dissection process on probability paper which is based on 
personal judgement. These points of dissection are the 
inflexion points of the plot or where the curve deviates 
most from its general direction. The selection of this point 
of greatest deviation was most difficult and was probably the 
largest source of imprecision with the method. However, all 
distributions resolved into two, three or four Gaussian 
components and this added to the confidence of the method.
Poor selection of dissection points would result in a larger 
number of Gaussian components being resolved and the selection 
of components to be used for the normal range would then 
have been the problem encountered in the method of Bhattacharya.
The resolved components were recombined and tested for 
significant distortions from the original distribution. The 
Chi-square test was used to detect these-distortions. The 
d-test of Kolmogorov-Smirnov was initially used for this 
purpose however, it is not designed for use with derived
data since in this situation the distribution of the maximum 
deviation is unknown and the critical level of d may need to 
be reduced for a given level of significance (oc). The 
K-^-S test is simple to use and requires less work than the 
Chi-square test. It was observed using both techniques that, 
the K-S test was less strict than the Chi-square test for the 
same level of significance, indicating that the critical 
value for d was too high. A further problem with the K-S 
test is that in both theoretical and observed distributions 
the extremes of the cumulative frequencies are either zero or 
n and therefore at these points d is also zero. The values 
of d in the tails of the distribution therefore approach zero 
and are relatively unimportant to the test* The Chi-square 
test on the other hand uses discrete class frequencies and 
the contribution each cell makes to the X 2 value depends 
not on the position of the cell in the distribution but on the 
square of the differencesbetween the observed and expected cell 
frequencies relative to the expected cell frequencies. . In 
this way the Chi-square test provides all cells with the same 
importance towards the "goodness of fit".
For most of the tests using unselected data this method 
produced clinically, acceptable normal ranges. Hov/ever, v/ith 
the selected data, Harding*s method produced a number of 
unrealistically narrow normal ranges. More robust methods 
such as the logarithmic transform method would be the method 
of choice for this selected type of data. Following the 
resolution of Gaussian components by the method of Harding
the percentile method of determining the normal range rather 
than the points of intersection method produced the' most 
acceptable limits based on current ranges.
The precision of the method of Harding was good even 
compared with the most robust logarithmic transform method.
Indeed the method of Harding showed the best overall precision 
of all the methods examined and this suggests that the selection 
of dissection points is not as random or arbitrary as first 
appears.
To evaluate these methods it is important to have prior 
knowledge of normal ranges to use as a standard for 
comparison. The tests used in this work are amongst the 
most commonly performed tests and have been in use for seven 
years in their present form. In this time the vast amount of 
experience accumulated with respect to the use and interpretation 
of these test results provides the standard by which the 
different statistical methods can be compared and evaluated.
Table 1.16 shows the normal ranges currently in use in the 
laboratory of the Royal Sussex County Hospital and Table 1.17 
lists the statistical methods examined and the number of 
times each method gave acceptable normal ranges for each 
type of data*
Table 1.16- ' Current Normal Ranges used in the Biochemistry
Laboratory of the Royal Sussex County Hospital
Bilirubin 5 - 17 umol/1 (+2)
Alkaline Phosphatase 21 - 92 U/l (+15)
LDH 70 - 190 U/l (+15)
Total protein 60 - 80 g/1 (+2)
Albumin 33 - 48 g/1 (+2)
AST 3 - 1 5  U/l (+2)
Calcium 2.15 - 2.60 mmol/1 (+0.05)
Phosphate 0.60 - 1.40 mmol/1 (+0.08)
Sodium 132 - 143 mmol/1 (+D
Potassium 3.2 - 4.8 mmol/1 (+0.2)
Urea 2.0 - 7.6 (+0.6)
The figures in parentheses show the ranges within which the 
normal limits must lie before the statistical method is 
awarded a point in Table 1.17. These ranges have been selected 
to represent a clinically acceptable degree of error in the 
determination of a normal range.
Table 1.17 Scores for each Statistical Method with
both Selected and Unselected Data
Group A
Group B
Group C 
Group D
x + 2s 
Percentiles
Cyclic Cumulation 
Percentiles 
Waid’s Method- 
Hoffman's Method
si
s2
Simple Cumulation 
Percentiles 
Waid's Method 
Hoffman's’Method
81
82
Transformation Method
Resolution Methods
Bhattacharya
Becktel
Harding (Percentile) 
Intersection
Selected
6
7
Unselected
3
1
Table 1«17 shows the number of successes each method scored 
in the calculation of clinically acceptable normal ranges.
It can be seen that with the selected data a number of methods 
are useful, especially the s«j estimates of the simple cumulation 
plot and the logarithmic transformation method. Furthermore 
the Group D method of Harding using unselected data produced 
clinically acceptable ranges as many times as the more robust
statistical methods with selected data. Except with those 
methods employing a resolution process, the unselected data 
produced clinically unacceptable ranges in more than 50 per 
cent of the tests. The selected data produced a higher 
proportion of acceptable ranges with most methods but was 
disappointing in its overall performance with such robust 
methods as percentiles and x + 2s.
For use with selected data the transformation method is 
preferred since the calculation of percentiles from a straight 
line log-Gaussian probability paper plot is likely to be more 
robust than the estimates of the s^  standard deviation 
calculated from two percentiles which do not consider the 
total distribution form and are therefore more susceptible 
to sampling variations.
Clinically useful normal ranges with the unselected data 
were produced most often by the percentile limits following 
the resolution technique of Harding and this is the method of 
choice for such data. This method was further tested with 
data from a new test being introduced into the laboratory at 
the Royal Sussex County Hospital. The test was plasma gastrin 
and 170 results were collected for analysis. This test is 
expensive and had not, at the time, been used on selected 
people for the determination of a normal range. The normal 
range was calculated by the method of Harding and this range 
is still in use without modification three years later.
In conclusion normal ranges should, if possible, be 
derived from and include the bulk of results from a large
sample of people who have no atypical or unusual manifestations 
compared with their individual and population norms. In the 
event that this type of data are unobtainable then a large 
sample of selected patients will provide useful ranges.
Reliable and robust statistical methods should be used and 
the logarithmic, transformation of results to a Gaussian 
distribution allows the theoretical and practical advantage 
of Gaussian statistics to be utilised. If however, the only 
data available are routine patients’ results and prior 
selection of patients is not possible then the less robust 
method of Harding is a useful tool for resolving clinically 
acceptable normal ranges.
.1
SECTION 2
Analytical and Biological Variations 
and the Normal Range
2,1 Introduction
Analytical Variation
The two types of analytical variation, accuracy, which 
is a measure of the agreement between the observed result and 
the true value, and precision (reproducibility of the method) 
will affect (respectively) the position of the normal range 
and its width.
Chemical and statistical methods both contribute to the
variation in normal range estimates.
Assay variation is illustrated by reference to the results
from four methods used by Fessel et al, (1964) for the
determination of albumin in plasma:
Method Mean SD
Biuret 5.2 g/100 ml 0.40 g/100 ml
Electrophoresis 4.1 g/100 ml 0*47 g/100 ml
Ultra centrifuge 6.3 g/100 ml 0.49 g/100 ml
HABA. dye 5.1. g/100 ml 0.65 g/100 ml
(HABA - 2-(4T-Hydroxyazobenzene) benzoic acid)
Variation in accuracy is shown by differences in the
mean values and variation in precision by the differences in
standard deviation.
An example of the' effect of methodological accuracy on
•the estimates of the normal range is provided by a study of
methods for the measurement of aspartate aminotransferase.
When Karmen (1955) first developed the ultra-violet
method, temperature controlled cuvettes were not available
and reagents such as NADH (Nicotinamide adenine dinucleotide, reduced)
were expensive and of questionable purity. Karmen reported 
a normal range of 5 to 33 units. For several years most 
authors used a ‘normal1 range of 10 - 40 units but without 
much evidence for its correctness. The use of optimum 
concentrations of reagents and controlled cuvette 
temperature produced a normal' range of 10 - 25 units at 
25°C.
Knowledge of the precision of a method is important
for interpreting normal- ranges. If the precision is poor
then the overlap between normal and -abnormal - will be
large and the results less meaningful.
The observed dispersion of biological data is a
composite of true biological variance « C  ) and analytical
B
2 2 ^  2 2
variance M .  ) and has the relationship
a JjA a a
2 2This leads to the standard deviation BA B * A
It can be seen that if one standard deviation cfT or <5”! is
A B
more than double the other, the'larger obscures the effects
of the smaller. Thus, if the analytical error were a fourth
of the normal range as postulated by Tonks, (1963), the
observed biological distribution would hardly be distorted
by method error. may be assumed to be constant for a
physiological constituent in steady-state condition and
therefore is a more valuable parameter than inBA
inter-laboratory comparisons of normal ranges. (Si may
B
be calculated from the difference between the total variance
2 2 
^BA and the analytical variance <5^  since,
0 2
^3 ~ ^BA - Cf"--)' According to Gowenlock and Broughton (1968)
the precision of a method (<rA) is best calculated from 
between batch data. These data not only include those 
errors relating to the complexity of the analytical method 
but also errors caused by standardisation material and 
variations in the quality of analyst, instruments and 
other equipment required. Errors due to the standardisation 
material may initially be regarded as an accuracy problem, 
but if over several days*, analyses this inaccuracy is seen 
to fluctuate about an accurate mean then on this time scale 
the variation is regarded as a precision problem.
The normal range is therefore a composite of variations 
derived from a number of different sources. Another source 
of error is the statistical method used for the calculation 
of the ranges. For example, it has been shown in this thesis 
that the method of Bhattacharya is less precise than other 
methods investigated. In addition, the size of the sample 
will affect the precision with which the normal range represents 
the whole population. The variance of a small sample is less 
likely to approach that of the whole population, than the 
variance of a large sample. Reed et al (1971) recommended 
the use of at least 120 subjects for a reliable percentile 
estimate of the normal range. This number may sometimes be 
inadequate with variables which have a large biological and . 
analytical variance. The minimum number of observations in 
a sample will also vary with the statistical method used for 
the determination of the normal ranges. Parametric and in
particular methods based on the Gaussian distribution utilise 
data more efficiently than non-parametric methods and therefore 
require less data for the same degree of precision. Mainland 
(1969) stated that samples of 100 or more showed little 
difference in precision, whereas samples of 50 or less gave 
unreliable estimates of means and standard deviations.
Flynn et al (1974) stated that the Percentile method 
recommended by Herrera (1958) has an efficiency of no more 
than 50 per cent which means that to obtain the same precision 
as a Gaussian method tv/ice as many subjects would be needed. 
However, with a Gaussian distribution, the percentile and 
Gaussian methods give similar results for a given probability 
interval and as the distribution departs from Gaussianity these 
two methods give increasingly divergent results. It is 
impossible to say which is more correct and it is incorrect 
to use Gaussian parameters as standards of efficiency for 
anything but Gaussian distributions.
The sample size required for reliable- percentile 
estimations depends on that part of the distribution which is 
of interest. For example, if the bulk of data lie about the 
50th percentile then this can be determined reasonably 
accurately with as little as 50 to 100 observations. However, 
even with a sample size of 400, an estimate of the 2.5th 
percentile may be unreliable since its position, in this case 
10 observations in from the tail of the distribution, remains 
exposed to the effect of sampling variations.
In conclusion, normal ranges should be calculated from
data produced from several days* analyses. A sample size of 
at least 100 different people or patients should be used 
depending on factors already discussed and these should 
accurately represent the type of population for which the 
normal ranges are to be. used. If a method is changed its 
analytical variance may also alter (Williams jet al, 1970) 
which will affect the interpretation of results and normal 
ranges, (Whitehead, 1972). The problem of analytical 
variation'can, at least in part, be overcome by an effective 
quality control scheme (BUttner, 1965). Specificity, and 
variation may be checked by intra- and inter- laboratory 
quality control using calibration and reference materials.
Such procedures often give unpleasant but useful surprises 
showing that the total variance is much greater than 
originally realised.
Biological Variation 
Biological variation, as measured by its standard 
deviation dl may be measured indirectly using the 
relationship d^ = There are many factors
contributing to biological variation which may affect - normal- 
ranges but a number of these can be eliminated by the identical 
preparation of each patient before blood is sampled (Fawcett 
and Wynn, 1960). For example by taking a fasting blood at a 
fixed time of the day, variations produced by different diets 
and circadian rhythms are eliminated. Other factors, which 
cannot be standardised, such as age and sex may require
separate ranges. However, the greater the number of factors 
contributing to biological variation which are considered, 
the more difficult is the interpretation of routine 
biochemical data.
Age Alkaline phosphatase activities and potassium, bilirubin 
and phosphorus concentrations all vary during childhood 
(Archarya and Payne, 1955; Tolls et al, 1970 and Bauer and 
De Vino, 1970). Alkaline phosphatase shows the most variation, 
the activity at birth being 2.5 times the normal adult activity 
and 1.0 - 1.5 times the pre-pubertal activity. Alkaline 
phosphatase and Lactate Dehydrogenase (LD) show elevated 
activities in geriatric patients compared with other age 
groups, in contrast, potassium, bilirubin, phosphorus, 
total proteins and albumin concentrations all decrease with 
age (V/ilding et al 1972; Craig and Bartholomew, 1970;
Norris and Schock, 1961; Reed et al, 1972; Chen and 
Millard, 1972). McPherson _et al, (1978) found an increase 
in potassium concentration with age while total protein, 
albumin, calcium and inorganic phosphate tended to fall 
progressively. Werner et al (1970a) demonstrated an increase 
in plasma calcium concentration in men aged between 30 and 
80 years. Chen and Millard (1972) found lower aspartate 
aminotransferase (AST) results in v/omen in their 3rd to 
5th decades than men of the same age, and McPherson at al 
(1978) showed that the male level does not alter with age 
but the female level starts 20 per cent lower and after the 
menopause increases sharply towards male levels. A significant
increase in plasma sodium concentrations in women at the 
menopause has also been shown (McPherson et- al, 1978).
Stekelenburg et al (1973) studied the age dependency of 
certain blood constituents in children between the ages of 
4 and 13 years. They found variations associated with the 
’'mid-growth spurt” between the'ages of 6 and 8 years. Plasma 
urea concentrations decreased and total protein concentrations 
increased.
Goldberg et al (1973); Keating et al, (1969);
Werner et al, (1970a); O’Kell and Elliot (1970);
Reed et al (1972) and McPherson et al (1978) demonstrated 
an increase in plasma urea concentrations with age.
Roberts (1967) noticed this increase with age only in women.
Cohen ej; al (1967) showed that the activity of LD 1 
isoenzyme is higher in young women than in postmenopausal 
women whereas the activity of LD 2 isoenzyme is higher in 
the postmenopausal group.
Sex Plasma alkaline phosphatase and AST activities, albumin, 
bilirubin, calcium and urea concentrations have all been shown 
to be higher in men.than women (Winsten, 1976; Wilding et al, 
1972; Dent and Harper, 1962; O’Kell and Elliot, 1970;
V/erner at al, 1970b; Cunninck et al, 1969; Chen and 
Millard, 1972; Goldberg et al, 1973; Keating et al, 1969;
Reed at al, 1972; O’Hagan at al, 1957; Goldberg and 
Winfield, 1974; Keating ej; al, 1964 and McPherson et al, (1978). 
Plasma urea concentrations in men are up to 0.75 mmol/1 
higher than in women (Flynn, 1969). Winsten (1976) suggested
that calcium results above 2.50 mmol/1 in women should 
arouse suspicion.
Mean plasma phosphorus concentrations were found to be 
higher in women than in men, the difference becoming 
significant only in the 5th decade (Greenberg at al, 1960; 
Keating 'et'al, 1969 and Hamilton £t al, .1956). A similar 
trend was demonstrated by McPherson et al, (1978).
Race Total proteins, albumin, urea and potassium 
concentrations and LD activities have all been shown to 
vary between races. Comans (1957); Holmer et al (1951) 
and Karayalacin at al (1973), demonstrated a difference in 
plasma globulin concentrations between white Caucasian men 
and coloured men from the United States. Black Ugandan 
people and Western European people showed differences in 
plasma urea concentrations (Barnicot and Sol, 1954, and 
Macfarlane et al, 1970). All these biochemical differences 
may be due to specific environmental rather than genetic 
differences.
Circadian and Seasonal Rhythms In 1965 Winsten suggested 
that blood specimens should be obtained after an overnight 
fast or at least 4 hours after a meal. It has been shown 
that alkaline phosphatase, bilirubin, sodium, potassium and 
urea all show diurnal variations. Statland _et al (1973) 
demonstrated a peak plasma sodium concentration at 1100 hours 
v/hich was up to 4 mmol/1 higher than levels seen at 800 or 
1400 hours. Potassium concentrations decrease from 800 hours 
to 1400 hours.
Harvard and Reay (1925) demonstrated seasonal variations 
in serum inorganic phosphorus concentrations. Concentrations 
in adults were found to be lowest in Spring and highest in 
August.
Other Factors The effects of strenuous exercise and diet 
have also been investigated by Statland et al (1973).
Exercise was seen to affect plasma potassium, phosphate, 
total protein and albumin concentrations and a noon meal 
affected sodium and phosphate concentrations and alkaline 
phosphatase and LD activities.
- , Pregnancy decreases plasma calcium, urea, total protein 
and albumin concentrations and increases alkaline phosphatase, 
LD and AST activities (Elliot and O'Kell, 1971).
A report by Lewis et al (1957) states that plasma urea 
concentrations 'are.lower in smokers.
Stress tends to increase the variability of the 
concentrations of plasma constituents whereas the use of 
basal conditions may reduce it (Sollberger, 1954). Tolerance 
tests have a similar effect by virtue of the fact that values 
forced against a functional upper limit have less variability 
than the dynamic intermediate levels.
Williams et al (1970) and Harris et al (1970) carried 
out a detailed study of long-term biological and analytical 
components of variation in 68 normal volunteers over a 
10 - 12 week period. Values for AST, sodium and calcium 
showed that the analytical component of variation was greater
than thb individual biological component and the. discriminating 
power of these tests would benefit greatly by a reduction in 
analytical variance.
Levin et al (1973) showed that the analytical variance 
for alkaline phosphatase and AST contributes considerably to 
the total within-person variance and when this was allowed for, 
the true biological variance for the individual was small.
Harris and De Mets (1972) stated that a chemical test
will contribute to the 'individuality' of a blood 'profile'
only if the individual plus analytical components of
variation total is less than the inter-individual variation,
i.e. Sp/sGd  where s? is the mean standard deviation of
each individual's results and sn is the standard deviation
l i
of the group of individuals. For sodium, potassium, calcium, 
AST and LD this ratio was found to exceed 0.9 which suggests 
that these tests contribute very little to a blood‘chemical 
'profile1. It appears that most of the personal variance 
Sp for sodium is contributed by the analytical variation 
and if this is reduced sodium would become a highly 
discriminating test. Flynn et al (1976) demonstrated that 
there was little scope for reducing normal ranges by 
improvement of the within-batch precision. The between- 
batch precision on the other hand gave cause for concern 
since it contributes noticeably to the normal range of 
several constituents, in particular the electrolytes and in 
the worst case, calcium, to the extent of 29 per cent.
It has been suggested (Sollberger, 1969) that other 
large sources of variation such as inter-individual scatter 
in space and intra-individual fluctuations with time may be 
reduced using correlation regression methods with one or 
more covariables. However, at the present time, it is 1 
impossible to control all the factors known to contribute 
to biological variation, but some of the more serious causes 
of variation may be eliminated using more specific normal 
ranges which have been accurately defined. Presented in 
this thesis are normal ranges calculated for different 
decades of age and for separate sexes. For the age group 
0 - 18 years shorter time intervals than decades are 
required and in the post-natal period normal ranges 
should ideally be calculated at fortnightly or monthly 
intervals. Unfortunately, in the health area covered by. 
the Biochemistry department at the Royal Sussex County 
Hospital, there is only a small children's hospital and 
sufficient data for these years could not be collected.
2.2 Methods
'Normal' Ranges for Different Age Groups and Sexes
Patients were classified into seven age groups,
0 - 1 0  years, 11 - 20, 21 - 30, 31 - 40, 41 - 50, 51 - 60 
and 61 onwards. M300 data were collected and the sex of 
each patient noted so that a further subdivision could be 
made. The two sexes and seven age groups together with the 
11 chemical analyses provided 154 frequency distributions.
These were plotted and the Kolmogorov-Smirnov (K-S) test 
(Kolmogorov, 1933 and Smirnov, 1939) used to detect differences
between all combinations of age groups and sexes within each 
group (Appendix 9 ). The differences were considered 
statistically significant when they exceeded that difference 
expected in 5 per cent of random samples from the same 
population.
Data for the 0 - 1 0  age group was not sufficient to 
permit useful estimates of normal limits and comparisons 
with other age groups. '
Normal ranges were calculated using the method of 
Harding. These calculations were made on all the frequency 
distributions.
The means of each frequency distribution were calculated 
as a measure of central tendency and plotted graphically to 
illustrate the differences between age groups and the two 
sexes.
The distribution variances were also calculated for the 
resolved normal component so that the effect of age and 
sex on the spread of results could also be observed.
The' Effect of Different Components of Variation on the
Interpretation of Normal Ranges
2 2 2Using the relationship s (total) = s (analytical) + s
(biological) the biological variance can be calculated if 
the total variance and the analytical variance (between-hatch) 
is known (Barnett, 1968). The analytical, between-batch 
variances were calculated from the results of control sera 
having values in the normal range. The total variances 
were taken from the parametric estimate of the normal- range.
In order to represent the strictest possible case, the 
smallest total variances were used which were obtained 
from the results of the investigations into the effects 
of age and sex.
2 2
Prom the relationship + s^ ) where s^
represents the standard deviation of the biological component
and s. that of the analytical component, s_. can be calculated 
A  J d
knov/ing the value of s ^  and s^. is the total standard
deviation' observed in the frequency distributions for
estimating normal limits and s^ is the betv/een-batch
standard deviation. The ratio s./s-n demonstrates theA B
relative sizes of the analytical and biological components 
of variation.
The reliability of this exercise depends on the . 
accurate assessment of the methodological error 
(Gowenlock, 1969; Krause et al, 1975)* As recommended 
by Gowenlock all samples used for the between-batch precision 
were analysed over a long period of time (three years) and 
handled by all the technical staff used for the processing 
of patients* samples. However, control sera were not 
disguised as patients* samples since, with automatic 
printing, of results - the opportunity for personal bias 
was greatly reduced.
RESULTS AND DISCUSSION
Effects of Age and Sex on Normal Ranges
As expected age contributed more to the biological 
variation of the normal range than the sex of the 
individual. With a number of tests the differences in 
the estimates of the means with age did not reflect a (
shift in position of the distribution along the x axis 
but were due to a change in the shape of the distribution 
and the position of the mode. For example, the albumin 
distribution for 21 - 30 years age group was platykurtic 
by comparison with the 61 years onwards age group and it 
v/as this broad peak extending over the higher concentrations 
of plasma albumin which resulted in the difference between 
the means. •
In the tables 2.1 - 2. !0 of results the quot.ed variances 
relate to the resolved normal component.
Bilirubin
Table 2.1 shows the results for bilirubin. The means 
for each age group and sex are plotted and the normals and 
'between-age group* differences noted. A sex difference of 
approximately 2 jimol/1 was found for most age groups except 
the greater than 61 years group. The means and the normal 
range estimates suggest that women have lower bilirubin 
levels than men. Bilirubin results in women showed no age 
variation and had a mean of means of 11 ^imol/1. Mean levels
Table ge1 Age and Sex Differences for Bilirubin
Age Group Sex 
(years)
Age Groups (years)
11-20 21-30 31-40 41-50 51-60 61-
11-20 M - N D D D
F - N N N N N
21-30 M - N D D D
F - N N N N
31-40 M - N D D
F - N N N
41-50 M - N N
F - N N
51-60 M . - N
F ■ - N
Sex Differences 
within Age Groups
Variances for M 
each Age Group F
D
32.6
25.8
D
24.1
14.3
D
14.9
14.5
D
19-.5
12.7
D
21.3
20.^ 5
N
21.6 
. 22.3
'Normal' M
Ranges
F
3-21
3-14
3-17
2-15
3-15
3-15
3-15
3-15
5-14
3-15
2-19
2-19
Sample SizesM 186 240 217 233 . 248 217
F 222 235 216 ?33 248 217
D = Different K * Not Different
Bilirubin Means for Each Age Group and Sex
Bilirubin Qumol/l) Age Groups (years)
t6 11—20 21-30 31-40 41-50 51-60 61-
T4
12
to
8
Means for Male Subjects
 Means for Female Subjects
for men however, did fall slightly with age. The oldest
j
age groups for both sexes showed the widest normal range 
2 - 19 umol/1. The variance of the normal component was 
smallest in the 20 - 50 year age groups and widened with 
both a decrease and an increase in age.
These results were similar to those of Roberts (1967) 
but the slight decrease with age observed with the means in 
male subjects was not demonstrated by V/ilding et al., 1972.
Alkaline Phosphatase (Table 2.2)
Women were found to have lower levels than men up until 
the 6th decade (51 - 60 year group) when there was no sex 
difference. The sex difference for the means v/as greatest 
in the 1 1 - 2 0  year group where the normal range for male 
subjects v/as 21 - 106 U/l. Werner et al., (1970a) also 
demonstrated higher levels in male subjects in this age group. 
Lowest alkaline phosphatase results for both sexes occurred in 
the 3rd decade (21 - 30 years). A slow increase in alkaline 
phosphatase levels was seen throughout life in men but women 
showed a sharp increase in the 51 - 60 years age group which 
coincides with the menopause for most v/omen. Between the 
ages of 11 and 30 years there was a fall in activity in both 
sexes but the average age at the time the fall occurred v/as 
higher in men. The fall v/as also more acute in men than women. 
These findings agree with I£cPherson et al (1978) and are consistent 
with the fact that the growth spurts responsible for increased 
enzyme activity in this age group continue later in men than 
women. Variances of the normal component were smallest in 
women in the 30 - 50 year age group.
Table 2.2 Age and Sex Differences for Alkaline Phosphatase
Age Group !Sex Age Group (years)
(years) 11-20 21-30 31-40 41-50 51-60 61-
11-20 M - D D D D D
F - D D D D D
21-30 M - - D D D D
F - • * N' N ' D D
31-40 H - - - A D D
F - - - N D D
41-50 M - - - - N N
F - mm - D D
51-60 M - mm - - - N
F cm - - - N
Sex Difference 
within Groups D D D D N
N
Variance M 1949 319 497 m 504 426
within Groups F 659 483 192 234 582 682'
'Normal* M 21-107 14-85 7-99 21-92 21-92 21-99
Ranges F 14-85 14-64 14-71 21-92 21-92 21-99
Means of Alkaline Phosphatase Activity for Each Age 
Group and for Each Sex
Activity Age Groups (years)
(U /1) 11-20 21-30 31-40 41-50 51-60 61-
90
80 ____
70
40
.Sample Si% e s M 168 244 209 230 241 224
F -233 239 209 230 241 224
----- y—  Means for Men
Means for Women
Lactate Dehydrogenase (Table 2.3)
This followed a similar pattern as alkaline phosphatase 
in women. In men LDH activity decreased in early adulthood 
and then increased steadily by approximately 20 —  25 U/l 
throughout life. These results agree with those of 
Werner et; al (1970a). Men in their second decade of life 
showed higher plasma LD activities than women in their 
second decade. The reverse v/as seen for the 6th decade.
The variances of the distributions were again smallest in 
the middle age groups and as a result these showed lower 
upper limits of normal than the other groups.
Total Protein and Albumin (Tables 2.4 and 2.5)
Plasma concentrations of both analytes were found 
to fall throughout life, total protein slowly until the 6th 
decade and then much sharper. Albumin has a steeper rate of 
fall than total protein in the first six decades and also 
increases its rate of fall in the 61 years onwarcfe age group.
The variance of the normal component was found to increase 
with age.
Sex differences were found to be of borderline significance 
in certain age groups but there was no pattern to the results 
and therefore their clinical significance is doubtful. There 
is some, disagreement in the literature regarding the effect 
of sex on total protein results but in a number of investigations 
albumin levels were found to be higher in men below 50 years 
of age (Wilding et al, 1972; McPherson et al', 1978; Roberts, 1967).
Table r2<3 Age and Sex Differences for Lactate Dehydrogenase
Age Group Sex Age.Grpup..(years)
(years) 11-20 21-30 31-40 41-50 51-60 61-
11-20 M - D N N N D
F - D N D D D
21-30 M - - N D D D
F - - N D D D
31-40 M - - - F D D
F - - - D D D
41-50 M - mm - - N D
F • - mm - - D D
51-60 If - - - - D
F - - - - - D
Sex Differences 
within Groups D N N N D
N
Variances in M 1467 1373 1325 942 1274 1218
age groups F 980 1163 713 734 1498 858
'Normal' M 64-185 64—166 69-175 80-165 70-180 80-17<
Ranges F 66-170 62-170 68-160 80-165 85-170 80-17<
D= Different N= Not Different
.. _ Lactate Dehydrogenase Means for Each Age Group
and for Each Sex
Lactate^Dehydrogenase Age Group (years)
11-20 21-30 31-40- 41-50 51-60 61-
160
150 ______
140
130 — ___________________  ______
120 m n  -
Sample Sizres M 184 "228 212 230 244 229
F 220 231 204 230 244 229
" Means for Male Subjects
-------- Means for Female Subjects
lauio *♦4 ak« aim, oex innerences ior Toxai Jreotein
Age Group Sex Age Groups (years) *
11-20 21-30 31-40 41-50 51-60 61—
11-20 M N N N D D
F D D D D D
21-30 M - N N D D
F - D N N D
31-40 M - - mm N D D
F - - - D N D
41-50 M mm - N D
F - mm - D D
51-60 M - - - - - D
- - - - D
Sex Differences ' 
within groupB D N N D D
Variances in 
Each Group
M 32 
F 40
38
37
39
31
40
41
47
49
56
59
•Normal* M 64-82 62-84 60-84 62-82 61-83 60-83
Ranges F 62-84 61-83 61-84 62-81 60-84 60-81
D= Different Nss Not Different
v.-'... v
Total Protein Means for Each Age Group and
Each Sex
Total Protein
T e / T j 11-20
Age Group (years) 
21-30 31-40 41-50 51-60 61-
76
74
— — •• — — —
—
72 ---
70
68
Sample Sizes _.M 191 — — 231 217 244 253 244
]F 245 -231 219 244 253 244
Means for Male Subjects 
Means for Female Subjects
Table 2.5 Age and Sex Differences for Albumin %
Age Groups
d \
Sex Age Groups(years)
(years) 11-20 21-30 31-40 41-50 50-60 61-
11-20 M - N D D D D
F - D D D D D
21-30 M - - D D D D
F - - D D D D
31-40 M - - N D D
. F - - - D D D
41-50 M - - - - D D
F - - ' - - D D
51-60 M - - - . D
F - - - - - D
Sex Differences
within Groups N D D N D D
Variances M 25 17 33 29 34 34
within Groups F 25 22 17 22 24 31
'Normal* K 36-50 36-50 36-49 33-48 35-48 35-48
Ranges
F 37-50 36-48 34-48 33-48 36-48 35-46
D= Different N= Not Different t
Albumin Keans for Each Age Group and Each Sex
Age Group (.years)
11-20 21-30 31-40 41-50 51-60 61-
40
#
38
36
Sample Sizes M 234 234 21;9 239 255 248
F 232 239 219 239 255 248
—  Means for Male Subjects
- - - - -  Means for Female Subjects
Albumin
( g / D
44
42
Aspartate Aminotransferase (Table 2.6)
This showed similar changes with both age and sex as LD 
Levels decrease between the ages of 11 and 30 years and then 
rise to a peak at 41 - 50 years of age in men and 51 - 60 in 
women. These peaks of activity also showed the highest 
normal range variances. AST activities then fall in the 
oldest age group. Women had lower levels than men except 
in the age groups above 51 years where there was no sex 
difference. The differences between the age group means 
did not appear to be due to differences in the positions of 
the distributions but due to a change in the shape of the 
distribution.and the frequency of results about the upper 
limit of normal .
Werner et al (1970a) found similar age and sex effects 
as described in this work, however, Wilding et al (1972) 
found a sex difference only up to the age of menopause but 
failed to show the fall in levels in early and late life. 
McPherson et al (1978) and V/ilding et al (1972) found that 
AST activities in men did not alter significantly with age 
although their work and that of Werner et al (1970a) disagree 
The work of Siest et al (1975) may hold the reason for this 
controversy. These workers examined the median and different 
percentiles within the distribution and showed that the lower 
the percentile the less was the variation of AST activity 
with age. Above the 90th percentile the increase in AST 
activity with age was marked and very significant. It 
appears therefore, that the relationship of AST activity with
Table 2*6 Age and Sex Differences for Aspartate
Age Groups Sex
Aminotransferase 
Age Group s (years)
(years) 11-20 21-30 31-40 41-50 51-60 61-
11-20 M - D N N D D
F - D D N N N
21-30 M - - D • D N N
F - - N D D D
31-40 M - - - N D D
F - - ' - D D D
41-50 M - - - - D D
F -■ - - - D N
51-60 M - - - - D
Sex Difference
F
" V
N
within Groups D D D D N N
Variance M 20 11 15 18 18 14
within Groups
F 14 9. 10 12 17 12
’Normal1 M 3-14 2-12 2-15 2-13 2-13 2-12
Ranges F 3-11 3-12 2-11 2-11. 2-13 2-12
D= Different N= Not Different -, •
Aspartate Aminotransferase Means'for Each Age 
Group and Each Sex 
AST Age Groups (years)
(U/l) 11-20 21-30 31-40 41-50 51-60 61-
10
9_________________________________ _____ _____
6
Sample Sizes M 174 220 203 209 237 221
F 230 220 203 209 237 221
■ ■ ■ ■■ 11 1 Means for Male Subjects
------ -  Means for Female Subjects
age is complex and dependent on other factors not usually 
considered. It is possible that the increase in AST activity 
seen in the middle years by some workers is not solely 
dependent on agebut is affected by some other commonly 
occurring factor and the two act synergistically. For 
example, the population sample used by Werner e_t al (1970a) . 
included 3000 visitors to the San Francisco Health Fair and 
these people, would probably have been subjected to relatively 
vigorous exercise compared with their usual daily routine.
This may have potentiated the effect of age on AST activity.
The consumption of alcohol may be another factor with which 
the magnitude of its effect on AST activity is age dependent.
Another complicating factor with enzymes is that most 
exist in a number of different forms called isoenzymes. These 
isoenzymes have different substrate affinities and therefore 
activities in a given reaction mixture. It is possible that 
the effect of age is not to increase or decrease the 
concentrations of the enzyme protein but to alter the 
proportions of each isoenzyme in the plasma and thereby produce 
an apparent change in activity. Different isoenzymes will 
require different reaction conditions to achieve maximal 
activity. Therefore a change in the type of isoenzyme present 
•may produce an increase or decrease in activity depending upon 
the reaction conditions. If different workers use different 
methods, buffers, pH and substrate concentrations then it is 
doubtful whether the effects of age or sex or any other 
variable seen by those workers can be validly compared.
The skewed distributions which are commonly found with most 
enzymes are also possibly due to the presence of isoenzymes.
Calcium (Table 2.7)
Levels were found to decrease in men throughout life, 
the fall being more pronounced in the elderly. Levels in 
women also fall in early adulthood but then increase in the 
years coincident with the menopause, between.the 5th and 6 fch 
decades. These results are consistent with most other 
workers. Sex differences were seen particularly in the 
21 - 30 year group when men showed the higher levels and in 
the 51 - 60 year group when v/omen had higher levels.
Inorganic Phosphorus (Table 2.8)
In men levels of this analyte decrease .slowly in early 
adulthood, stabilise in the middle years and then decrease 
again in the elderly. Women followed a similar pattern but 
the decrease was smaller in early adulthood and there was a 
sharp rise which was possibly due to the menopause, in the 
51 - 60 year age group, where the sex difference became 
highly significant. Following the rise there was a sharp 
fall in the 61 onwards age group. Differences in mean plasma 
inorganic phosphorur levels which were attributable to sex 
variation were therefore seen in all age groups except the 
21 - 30 year group. The results of this study are similar 
to those of McPherson e_t al (1978) except for the last age 
group where these workers found a steady increase in inorganic 
phosphorus levels. Wilding et al (1972) and Werner et al (1970a)
Table 2*7
Age Groups
Age and Sex Differences for Calcium
Sex Age Groups (years)
(years) 11-20 21-30 31-40 i VJl O 51-60 61-
11-20 M - N D D D D
P - D D D N D
21-30 M - - N N D D
P - - N N D D
31-40 M - - - N N D
P - . - N D D
41-50 M - - - - N D
F - - D D
51-60. M - - - - D
P - - - - . - D
Sex Differences 
within Groups
D D D D D N
•*2
Variances x 10 
within Groups
M
P
2*0
2vb
1*7
1*7
2.3
1.2
2.3
2.3
2*7 \
2;3
2*0
2-3
formal1
Ranges
M 2.10-2.63
2.
2
15-2.60
.15-2.58
2.13-2.
2.
60
13-2. 60
2.08-2,
P 2.15-2.58
2.
2
13-2.55
.13-2.55
2.13-2.
2.
60
10-2. 63
2.08-2,
D= Different N= Not Different
Calcium Means for Each Age Group and ach Sex
Calcium
(mmol/1) 11-20 21-30
Age Groups (years) 
31-40 41-50 51-60 61-
2.45
2.40
----- -----
2.35 « m  -~um
2.30
Sample Sizes M 
F
195
234
231
233
214
214
Means for Male Subjects 
Means for Female Subjects
224
224
247
247
240
240
Table .2.8
Age Groups Sex
Age and Sex Differences for Inorganic 
Phosphorus
Age Groups (years)
(years) 11-20 21-30 31-40 41-50 51-60 61-
11-20 M D D D D D
F D D D D D
21-30 M - - N N D D
p - N N D D
31-40 M - — . N N N
P - - D D D
41-50 M - — - N N
p -  - — • D N
51-60 M ' - - N
p - - D '
Sex Differences ^ 
within Groups
N D D D D
Variances in 
Groups(mmol/1)
M 0.07 
P 0.05
0.05 0.05 
0.04 0.03
0*05
0.04
0.04 0.05 
0.-04 0.04
’Normal1 Ranges M 0.65-1 
(mmol/1)
F 0.71-1
.62 0.58-1. 
0.58-1.36
.49 0.71-1. 
0.65-1.36
36 0 
0.61-1.29
36 0 
0.61-1.29
.65-1.29
0.69-1.
.69-1.42
0.69-1.
D= Different N- Not Different
Inorganic Phosphorus- Means for Each Age Group
and Each Sex
Phosphorus
(mmol/1) 11-20
Age Groups (years)
21-30 31-40 41-50 51-60 61-
1.20
1.15
1.10
*
1.05 wmwmmmm
1.00
0.95
ample Sizes M 193 227 213 235 247 241
F 243 234 213 235 247 241
Means for Male Subjects
--------- Means for Female Subjects
also showed this increase following the age of menopause.
Wilding _et al (1972) showed higher levels in women at all 
ages and this work confirms these results. However in the 
11 - 20 year age group, which Wilding et al (1972) did not 
investigate, mean levels were higher in men.
In addition the variances as well as the mean levels
of both sexes in the youngest (11 - 20 year) group were 
greater than.in the other age groups.
Sodium (Table 2.9)
Sex differences were found in the 2nd and 3rd decades 
where women had lower levels. Male levels tended to be 
reasonably constant throughout early and middle life and 
then fell slightly in later years. Women showed increases of 
about 1 mmol/1 in the middle years then a fall in later life
to levels seen in early adulthood. 'These results are in
accord with those of McPherson et al (1978) and Wilding et al (1972).
The distribution variances appeared to increase with 
age, possibly because of a decrease in the efficiency of 
homeostatic mechanisms.
Potassium (Table 2.10)
As with sodium, levels in both sexes showed an irregular 
pattern with male levels being most stable. Men showed a 
slight increase in plasma potassium concentration between 
the 2nd and 3rd decades, then came a stable period up to the 
51 - 60 year age group from which a slight fall was seen.
Women showed fluctuating levels with the highest mean at the
Table 2*9 Af?€i and Sex Differences for Sodium
Age Groups 
(years)
Sex
11-20 21-30
Age Groups (years) 
31-40 41-50 51-60
*
61-
1T-20 M N N N D D
p • - N N D D D
21-30 M - - N N D D
F . — D D D D
31-40 ' M — - — N N D
F - — ■, N N D
41-50 M ■ - - • — - N D
F - — — - N D
51-60 M - - — - - . N .
F — — — — - . D
Sex Differences 
within Groups
D D N N • N N
Variances in M 
Groups (mmol/1)
9
9
11
9
10
9
13
9
16
14
16
17
'Normal* M 131-144 132-143 132-143 132-143 133-144 132-144
Ranges (mmol/1) ^ 132-142 132-142 133-142 133-143 133-144 132-144
D= Different [= Not Different *
Sodium Means for Each Age Group and Each Sex
Sodium Age Groups (years)
(mmol/1) 11-20 21-30 31-40 41-50 51-60 61-
139
138 ---- ---- « m m m a m mm m m m m
137 * to «««
136
Sample Sizes M 193 233 217 245 218 232
F 239 231 216 245 218 232
Means for Male Subjects
--- -- -- Means for Female Subjects
Table 2.10 Age and Sex Differences for Potassium
Age Groups 
(years)
Sex
1,1-20 21-30.
Age Groups (years) 
31-40 41-50 51-60
4
61-
11-20 M N N N N D
F ~ D N D D D
21-30 M — _ N N N D
F — _ D N D D
31-40 M — _ . - N N D
F — D N D
41—50 M — _ - - N N
F — _ - - D D
51-60 M — _ — - . - N>
F — - - — D
Sex Differences 
within Groups N D N N
N D
Variances in 
Groups (mmol/1)
M
F
Oi11 0.22 
0.20 0.23
0.18
0.20
0.25
0.-26
0*27
0V28
0.33
0.29
'Normal*
Ranges (mmol/1)
M
F
3.1-4.6 3.1-4.7
3.2-4.6 3.0-4.6.
3.1-4.8
3.1-4.8
3.1-5.0 
3.0-4.8
2.9-4.9
2.9-4.9
2.9-4.
2.9-4.
D= Different N= Not Different
Potassium Means for Each Age Group and Each Sex
Potassium 
(mmol/1 )
Age Group 
11-20 21-30 31-40
s (years)
41-50 51-60 61-
4.1 «mi m  m  m
4.0
m m  m m  mm
’ 3.9
• m  m
3.8
Sample Sizes M 193 242 218 227 239 244
F 243 213 215 227 239 244
Means for Male Subjects 
Means for Female Subjects
menopausal age group and the lowest levels in the oldest age 
group. Differences between men and v/omen were significant 
only in the 2 1 - 3 0  year age group and the oldest group. 
Distribution variances increased with age. McPherson et al (1978) 
demonstrated a steady increase in potassium levels with age 
in both sexes and on average male concentrations were nearly 
0.2 mmol/1 higher than females. Wilding et al (1972) also 
showed this age effect but found sex differences to be 
insignificant.
A possible reason for these discrepancies in the 
effects of age and sex on plasma potassium concentrations 
may'be the time of day the blood collections were made.
McPherson et al (1978) and Roberts (1967) both used blood 
donor patients and obtained the blood samples.between 0930 
and 1230 hours in the former survey and between 103Q and 1130 
hours in the latter. Wilding ejt al (1972) used patients 
attending a health screening' centre and in this work hospital 
patients were used. The time of blood collections for these 
surveys was not standardised. In this work the data was also 
collected oyer a two year period and Statland et al (1973) 
found potassium levels to have seasonal as well as diurnal 
fluctuations* These daily and seasonal fluctuations may have 
masked the small increase in potassium with age demonstrated 
b;y McPherson et al (1978) and Roberts (1967).
In support of the results of this work, it has been shown 
in many studies (Judge, 1968; Dali et al, 1971) that elderly 
people have a deficient potassium intake and that they are
easily rendered hypokalaemic. It is surprising therefore to 
see other workers finding increases in potassium levels with 
age. It is possible that the hospital diet is more deficient 
in potassium than the diets of blood donors and outpatients 
and it is also probable that the widespread use of diuretics 
in the elderly hospital population seriously affected the 
findings in the 61 years onv/ards age group.
The increase in potassium levels with age shown by 
McPherson ejt-al (1978) and Roberts (1967) possibly reflects 
the ageing process affecting the aldosterone/sodium resorption, 
potassium excretion process in the kidney. Potassium levels 
also increase in renal insufficiency and bear a direct 
relationship with plasma urea concentrations. If these 
were the reasons for the increase in potassium with age 
then a concomitant decrease in sodium concentrations should 
also be observed since they are related in a reciprocal 
fashion. McPherson et al (1978) did demonstrate a decrease 
in sodium as well as the increase in potassium concentrations 
with age in men and linens trusting women which supports this 
hypothesis.
J
Urea (Table 2.11)
In this v/ork the effects of age and sex on mean urea 
levels were consistent v/ith the findings of other workers, 
levels in both sexes increase with age and men have significantly 
higher levels than women. This difference between the sexes 
was found to be about 0.5 - 1*0 mmol/1 except in the last age 
group where the difference was not significant owing to a
Table i£.71 Age anu jca .ujlx jl —
Age Groups Sex Age Groups (years)
(years) 11-20 21-30 31-40 41-50 51-60 *61-
11-20 M - N D D D D
F - N D D D D
21-30 M - - : D D D D
F - — ■ D D D D
31-40 M - - N D D
F - - ' D D D
41-50 M • - - - D D
F - - — ■ — • ' D D
51-60 M - - . - - — D
F - - — — — . D
Sex Differences
within Groups D D D D D N
Variances in M V1*3 1.4 1.5 • 1.7 2*1 2.4
Groups (mmol/1) F 1.6 1*8 1*4 1.6 1*9 -2.4
’Normal* M 1 » CD 1 • o 2.3-7.3 2.0-7.3 2.2-7.6 2.3-8.6 2.3-8.
Ranges (mmol/1) F 1.5-6.0 1.7-6.6 2.2-6.3 1.8-7.1 1.8-9.0 2.3-8.
D= Different N= Not Different
Urea Means for Each Age Group and Each Sex
Urea
(mmol/1) 14-20
Age
'21-30
Groups (years) 
31-40 41-50 51-60 61-
7.0
6.5 -----'
6.0 -----
5.5
5.0 ----
4.5
mm m  mm
m  m m m  mm
4.0 *
Sample Sizes M 194 235 215 227 241 220
F . 236 235 216 227 241 220
Means for Male Subjects 
Means for Female Subjects
sharp rise of about 1.2 mmol/1 in women after 60 years of 
age. Wilding et al (1972) also found a significant upward 
trend in women but these workers observed this rise a decade 
earlier and attributed the increase to the menopause. From 
11 years of age to over 61 years of age the increase in 
plasma urea was found to be about 2.2 mmol/1. The variance 
of the normal components also increased with age.
Waters et al (1968) showed that the effects of age and 
sex on urea results cannot always be demonstrated in hospital 
inpatients. This may have been due to a poor protein diet 
minimising the increase in urea with age. However, these 
results have not been confirmed.
It is generally believed that the increase in urea v/ith 
age is a result of the loss of renal glomeruli which is 
probably secondary to vascular changes. The number of 
glomeruli in a kidney of a person over 70 years of age is 
usually reduced by one third to one half that of a healthy 
young adult (Chen and Millard, 1972).
The Effects of Biological and Analytical Components of 
Variation on the Interpretation of the Normal Range
It can be seen from Table 2.12 that bilirubin showed
the highest s./s,, ratio. Its analytical variation was A n
greater than- its biological variation. This suggests that 
bilirubin is not a sensitive index to disease. Sodium also 
showed a large analytical component of variation with respect 
to its biological component and this supports Gowenlock,s (1969)
Table 2,12 Comparison of Biological and Analytical
Components of Variance
TEST SA SAB SB SA/SB
Bilirubin 2.7 3.6 2.4 1.13 jumol/1
Alkaline Phosphatase 5 14 13 0.38 U/l
LD 11.9 26.7 23.9 Oi 50 U/l
Total Protein 1.2 5.57 5.44 0.22 g/1
Albumin 0.6 4.15 4.11 0.15 g/1
AST 1.4 3.00 2.65 0.52 U/l
Calcium 0.05 0.11 0.10 •0.50 mmol/1
Phosphate 0.06 0.17 0.16 0.38 mmol/1
Sodium 2.1 2.92 2.03 1.03 mmol/1
Potassium 0.1 0.33 0.31 • 0.32 mmol/1
Urea 0.3 1.14 1.10 0.27 - mmol/1
observation that a large part of the total variation' for 
sodium is due to non-biological reasons. He suggested that 
if practicable, specimens for sodium determination should be 
analysed more than once in order to reduce s^ to s^//w where w 
is the number of replicates.
AST, LD and calcium also showed a relatively large analytical 
variation compared with their biological components and this 
also makes accurate interpretation of these results difficult.
If the true clinical usefulness of these tests is to be 
realised, a better analytical precision is essential.
The introduction of fast multichannel analysers has 
improved analytical precision in two ways; firstly, by the 
precise timing of a sequence of steps in the chemistry 
method and secondly by facilitating the use of effective 
quality control schemes. However, most of these analysers 
have only single point calibration and rely on the accuracy 
of commercial quality control sera. Unfortunately, different 
brands of control sera and even different batches of the same 
brand do not always give consistent results (Helman _et al, 1971 
and-Dobrow and Amador, 1970), Whilst the within-batch precision
has therefore been improved, the between-batch precision has 
possibly remained the same. It can be seen however, from 
Ta.bles 1.1 and 1.2 (pages 50 and 51) that in most cases the 
within-batch precision is still a major part of the total 
analytical variation, especially with tests such as sodium,
AST and calcium. Reduction to negligible levels of the
within-batch analytical variation for sodium would reduce its 
normal range approximately 50 per cent. LD results however, 
could be greatly improved by reducing the between-batch 
variation using stricter quality control measures.
The ratio of analytical to biological variation needs 
to be considered when interpreting results. To illustrate 
this, consider a healthy and diseased population and their 
biological variances.
Distribution of Biological 
Variance only.
Distribution of Biological 
and Analytical Variance.
/ Healthy 
//Population
Units of Measurement
In this case there is complete separation of frequency 
distribution when only the biological variance is considered. 
Thus the diagnostic efficiency potential for this test is 
100 per cent. However, in addition to the biological 
variance there is also the analytical variance and if this 
is added to give the complete "real-life" situation then the 
diagnostic efficiency is much reduced and overlap between 
healthy and diseased populations is observed. It is for 
this reason that the high analytical variance for sodium 
prevents a slightly abnormal result from being interpreted 
in terms of health or disease as exactly as for example a
slightly abnormal potassium result. If the s./s,, ratios
A x>
2 2 2
are reanalysed in the relationship s s. + s,, then the
ajd a a
relative effects of each variance can be observed. For 
example, for AST the ratio (p.134) is 0.52, therefore
s2AB = SB2 + (0-52 SB )2
SAB2 = 12 + (°-52)2 S2b 
s2ab = 1*27 s 2 b
Thus the biological variance contributes 78.7 per cent 
of the total variance and the analytical variance contributes 
21.3 per cent. The albumin ratio (Table 2.12) of 0.15 
suggests that the analytical variance is negligible compared 
with the biological variance and therefore the potential 
.diagnostic efficiency of this test is good.
Albumin, total protein, alkaline phosphatase, inorganic 
phosphate, potassium and urea all showed good analytical 
precision compared with their biological variance and will 
therefore also have a good diagnostic potential. Bilirubin 
has the poorest analytical precision and as with sodium 
improvement of this precision could reduce the normal range 
by as much as 50 per cent. The results for calcium were 
similar to those for AST.
GENERAL DISCUSSION AND CONCLUSIONS
The general conclusions arising from this work can be 
divided into 3 separate sections
a) Normal or Reference - semantic aspects
b) Normal Range determination - practical aspects
c) Normal Ranges - Interpretation of Data, present
and future
a) Normal or Reference - semantic aspects
Since its introduction,. the word Reference1 has become 
in the minds of many laboratory workers and clinicians 
synonymous with the word 1 normal*. This is unfortunate 
since both words have an individual function in the 
vocabulary of data interpretation.
Normal ranges can be defined as a continuous series of 
the most commonly found values in a population, the' limits of 
which are based upon statistical inference and medical research 
and experience. According to the full Oxford English Dictionary (1933) 
* normal* is defined as ’’constituting, conforming to, not 
deviating or differing from the common type or standard, 
regular, usual*’.. ’Normality* is defined in the same volume 
as the ’’character or state of being normal” and ’norm’ is a 
’’standard model, pattern, type”. The term ’normal range’ 
has no defined association with ’health* and therefore the 
two are not interchangeable.
Some ranges must be called reference or desirable ranges, 
because they do not refer to the most commonly found results 
in the population, for example, cholesterol and uric acid (see 
pages 17 - 19 inclusive).
Disease reference ranges may also be used to describe the 
range of results most commonly found in a particular disease. 
Individual reference ranges and therapeutic reference ranges 
for drugs are two other examples in which the word ’normal* 
is inappropriate.
Finally, the remaining conclusions arising from this 
work c’an be summarised thus:
(i) Normal ranges are specific in that they describe 
the bulk of or the most commonly occurring series of values 
in any predefined population.
(ii) Normal ranges provide the only available empirical 
yardstick by which results can be assessed. Unfortunately 
health ranges, the ideal yardstick, are inaccessible.
. (iii) The use of the general term ’reference interval’ 
is meaningless unless it is qualified so that its statistical 
derivation or clinical function is made apparent.
b) Normal Range Determinations - Practical Aspects
After examining a number of different methods for the 
determination of normal ranges there is one conclusion which 
is inescapable; the problems involving statistics, medicine 
and biochemistry are so diverse that it is doubtful whether 
there will ever be a universally accepted method. There are 
however more constructive conclusions which have resulted 
from this work.
(i) The determination of normal ranges is a 
multidisciplinary problem. Statistical, medical and biochemical 
expertise is required if useful normal ranges are to be produced.
(il) In order to reduce sampling errors to an 
acceptable level so that the data accurately represents 
the test population, at least 100 and preferably 400 
subjects are required.
(iii) The greater the care taken to ensure the accuracy 
of this data, the easier and more reliable will be the 
subsequent statistical method.
(iv) Selected hospital patients as a source of data 
have been shown to produce clinically useful ranges with 
a number of statistical methods. Unselected hospital patients 
on the other hand produced poor, unusable ranges except with 
the modified method of Harding. This method although 
theoretically unsound produced surprisingly good results.
The use of hospital patients as a source of data, 
although less reliable than, for example, blood donors, has 
three compensating advantages: firstly the quantity of
data produced for most tests is enormous and readily 
available to all hospital biochemistry departments; secondly 
this never-ending supply of new data allows normal ranges to 
be .recalculated with new data whenever necessary; thirdly 
there are certain sub-populations for which data is only 
likely to be available under hospital conditions, for example 
children and elderly subjects.
(v) .The efficiency with which Gaussian statistics 
utilise data makes these methods very attractive. Transformation 
methods .which convert frequency distributions to the Gaussian 
form thereby allowing the correct use of these statistics, 
are therefore recommended with the selected type of data. ‘
c) Normal Ranges - Interpretation of Data, Present and Future
Reviewing and recalculating normal ranges has produced
changes in only two of the eleven tests examined and confirmed
the correctness of the other nine. The AST range has been
increased from 3 to 12 U/l to 3 to 15 U/l and the sodium .
range has also been widened from 135 to 145 mmol/1 to
132 to 144 mmol/1. Although these changes will reduce the
number of falsely abnormal data it is unlikely to have entirely
solved this .problem.
The introduction of multitest screening without
improvements in data interpretation has provided clinicians
with a difficult problem. It is well known that the number
of falsely abnormal results increases with the number of
tests in a profile. Schoenberg (1970) stated that if the
probability of a single test result on a healthy person
•being within the normal range is 0.95, then the probability
2of two test results being normal is reduced to 0.95 • If
N tests are used in a profile the probability that a healthy
Nperson will have all results in the normal range is 0.95 .
In order to reduce the number of false abnormals in a
multitest screen Best et al (1969); Schoen and Brooks (1970)
all said the normal range must be liberalised according to
the number of tests.in the profile so that for N tests the
probability of a single result of a healthy person being
N rwithin the normal range is v0.95« This multiplication of
probabilities describes the convolution of independent events
such as throwing two sixes with two dice has a probability 
2
of (1/6) and three sixes with three dice has a probability 
3
of (1/6) and so on. However, it cannot be assumed that
multiple tests on a single individual are independent events 
since tests such as calcium and albumin show some correlation. 
Another disadvantage of liberalising the normal range in this 
way is that the same probability of finding a normal result 
in a healthy person is being applied to all tests irrespective 
of the degrees of overlap of the normal and disease ranges 
and the cost of errors of false positive and false negative 
results. If clinically useful normal ranges are to be 
produced these factors need individual consideration for 
each test.
The rates of false positives and false negatives are 
the criteria by which clinicians judge the acceptability of 
a normal range. Therefore a method which circumvents the 
problems associated with the determination of normal ranges 
by evaluating reference ranges based upon clinically 
acceptable levels of false positives and false negatives 
may help to resolve this problem of interpreting multitest 
data.
The rates of false positives and false negatives are 
calculated thus:
false positive rate = number of people incorrectly diagnosed
__________ to have disease ___________
total number free of disease
false negative rate = number of people incorrectly diagnosed
_______ to be free from disease________
total number with the disease
Ideally, the reference range or normal range (according 
to its derivation) should be positioned so that both rates are
zero. However, most tests show an overlap of results between 
healthy and disease states so that a reference range calculated 
by this technique would be required to reduce the rates of 
false positives and/or false negatives to a minimum depending 
on its clinical application. Unfortunately there are a number 
of problems with this technique. For a given test the rates 
of false positives and false negatives will vary with the 
different disease groups studied. This may lead to the 
determination of specific reference ranges for the different 
disease populations. Such a scheme would be complicated to 
operate and may even be misguided in the situation where a 
patient suffers from more than one disease. For example, a 
patient who attends a rheumatology clinic and has blood taken 
for a routine biochemical profile shows a borderline AST result. 
The reference range based on rates of false positives for the 
rheumatology patient sub-population' is wide and more liberal . 
compared with that of the cardiology patient sub-pcpulation 
owing to the relative incidence of cardiac disease in the two 
groups. The AST result for this patient v/ould therefore 
probably be disregarded but a system such as this which 
deliberately reduces the chances of recognising the less 
common diseases must be questioned both logically and ethically. 
Furthermore, the higher incidence of myocardial ischaemia in 
the cardiac group diminishes the proportion and therefore the 
importance of false positives and increases the need to 
minimise the number of false negatives. Whether a range should 
be evaluated from the rates of false positives or false negatives 
depends largely on the clinical situation, but for tests such as
those in a biochemical screen or profile which are relatively 
non-specific for all but a few diseases, the choice is difficult.
The accurate assessment of the rates of false positives 
or false negatives with these non-specific tests is also 
difficult and subject to clinical bias. It may take many 
years to accumulate sufficient information on a wide range 
of diseases-. Certain tests such as cholesterol and uric acid 
have a prognostic value as well as diagnostic value and may 
require a long term study of a large number of patients 
before the rates of false positives can be ascertained.
There are numerous factors which alone or combined 
contribute to the production of false positives. Factors 
such as methodological precision, biological variability, 
environmental and dietary factors are all relatively constant 
or can be controlled to minimise their variability. However, 
the possibility also exists that poor diagnostic sensitivity 
and even unrecognised disease also contribute. Recognition 
of a new disease or an increase in the diagnostic sensitivity 
as well as improvements in methodological precision would 
therefore necessitate a lengthy review of the rates of false 
positives with the possible adjustment of the reference range.
The diagnostic problems of differentiating false positives 
from genuine positives is a major disadvantage of this method 
of data interpretation. If errors are introduced in the 
initial studies they will be perpetuated with the use of the . 
reference range. Furthermore, the concept of evaluating 
reference ranges based on the ability of clinicians to 
diagnose disease is-wrong since the absence of diagnosable
disease is not necessarily consistent with health.
The problem of false positives arising from the 
interpretation of multitest data with univariate normal 
ranges therefore remains unsolved. It is meaningless to 
attempt to assess the efficacy of multitest screening when 
it is known that the method of data interpretation is 
inadequate." Barnett ei; al (1970) also believed that it 
was premature to recommend the use of extensive multiple 
screening tests for either hospital admission or general 
populations and that multiple screening tests should be 
considered as research rather than service activities.
They rightly stated that the formidable laboratory problems 
were being solved far more rapidly than the problems relating 
to medical usefulness of results.
The study by Durbridge et al (1976), (Durbridge, 1976) 
3howed that an admission multiphase screen of about' 40 tests,
(not all biochemical) produced no improvements in such indices 
as morbidity, disability, distress and length of hospitalisation. 
However, the negative results may have merely reflected the 
shortcomings inherent in the approach to data interpretation.
In a study by Daughaday _et al (1969) 1831 patients were 
subjected on admission to hospital, to a profile of 12 
biochemistry tests. Only 40 per cent of these subjects had 
findings within the 95 per cent limits of the hospital’s 
normal concentrations; 60 per cent revealed one or more 
abnormal results, and half of these, or 30 per cent of the 
total, were considered medically irrelevent being only 
"slightly abnormal”': Twenty five per cent of the abnormal
values were explained by the disease causing hospitalisation 
and about 5 per cent of abnormals (3 per cent of the total 
admissions) showed an unexpected, but relevant medical 
finding leading to a definite diagnosis.
Bryan et al (1966) stated that patient profiling on 
admission was of great value. Medically significant, 
unexpected data was found in 1 in 20 patients admitted to 
one hospital and although some of the other results were 
not useful at the time, their significance may have some 
future use. •
Sackett (1973) said that multiphasic screening and 
periodic health examinations were accepted by the public 
although frequently not by those at highest risk of disease. 
In some patients a diagnosis could have been made months, or 
even years earlier if the patient had sought' medical care 
when symptoms were first noticed. .
A study by Schor e^t al (1964) showed that their 
overall capability of identifying a disease ante-mortem 
was only 51 per cent. They found valvular heart disease 
and peripheral vascular diseases easier to detect than 
coronary heart disease and malignant disease. The major 
cause of death, coronary heart disease, escaped detection 
almost as often as it was detected. Another interesting 
observation was that in younger men, the disease that killed 
was rarely diagnosed prior to death, but in the older age 
group the fatal disease was often less acute and diagnosed 
in the living.
. These observations highlight shortcomings, in the
diagnostic methods used at the time and- suggest that multitest 
screens with more sensitive diagnostic tests coupled with a 
more efficient use of data are required. The premature 
condemnation of multitest screening without improvements 
in the methods of data interpretation may overlook a valuable 
diagnostic tool. Furthermore, it must be remembered that 
multitesting in the clinical laboratory v/as introduced 
primarily to overcome the ever -increasing workloads. The 
majority of samples brought to the laboratory required 
analysis for the same 15 to 20 most common tests and 
therefore if the majority of these tests could be incorporated 
on a single multichannel analyser and use the-same specimens 
for all the tests it would save on sample volume, time and 
improve the laboratory organisation. The tests in these 
profiles were therefore not selected for their diagnostic 
specificity but for reasons of workload, methodological 
adaptability to the analyser, uniformity of anticoagulants 
and preservatives and stability of the analyte. It is 
therefore unrealistic to expect great diagnostic rewards 
from these tests. However, if the problems associated 
with the use of univariate normal ranges in conjunction 
with multitesting are to be overcome, the interpretation 
of laboratory data must be given a more reliable scientific 
foundation.
Sunderman (1975) saw the change to ’reference values’ 
as an important step toward establishing a scientific basis 
for the clinical interpretation of laboratory data. The 
importance of this step is difficult to understand since
it now appears that the scientific interpretation of 
laboratory data requires a different, perhaps multivariate 
approach. Justification for this can be seen from the 
physiological standpoint.
Although different organs of the human body are 
anatomically and histologically distinct and functionally 
specialised, they are by no means biochemically independent. 
Therefore a distortion of the biochemical equilibria within 
’a diseased organ is likely to cause secondary imbalances in 
matabolic pathways or homeostatic mechanisms associated with 
other organs. Failure to appreciate this may be to overlook 
a valuable diagnostic tool. A multivariate approach is 
therefore recommended to gain the maximum of diagnostic 
information from biochemical measurements. For example, a 
trace of protein in urine is considered by many clinicians 
to be insignificant, but Gabrieli (1969) showed that patients 
with trace proteinuria were also more likely to show raised 
blood urea concentrations.
If this type of pattern recognition can be applied on 
a larger scale so that all results from a patient1s biochemical 
profile are examined simultaneously and recognised as conforming 
to a particular pattern, be it normal or abnormal, then a 
powerful method of multitest data interpretation will be made 
available. The statistical techniques for performing this 
task have been available to clinical chemistry since 1955 
when Zieve and Hill first introduced this subject. The 
future of multitest analysers may therefore depend on the 
development of these multivariate techniques, in particular
the branch known as discrimination analysis. The principle 
of discrimination techniques is shown in Appendix 10.
As the number of recognisable diseases have increased 
from 5,000 to 30,000 since the turn of the century 
(Reichertz, 1967) it is not surprising that this statistical 
technique has been predominantly used to solve specific 
diagnostic problems (Baron, 1970; Fraser e_t al, 1971;
Agostini et al, 1974; Hamilton, 1977 and Solberg e_t al, '1975). 
Not only is -it possible for computers to store details of 
symptoms and signs of all diseases, thereby providing a 
valuable aid to diagnosis, but by using discrimination 
analysis, they may also produce a more efficient objective 
approach to the interpretation of data (Feinstein, 1969).
Baron (1970) concluded that more information is obtained 
when large numbers of biochemical variables are considered 
simultaneously than when they are considered indivi-dually. 
Ramsoe et al (1970) concluded that no single liver function 
test could substitute the information contained in nine tests 
examined simultaneously.
This increase in information obtained from the 
simultaneous examination of multitest data may also reveal 
normal patterns even when there are one or two tests in the 
profile outside the univariate normal ranges. The problem 
of false positives may be considerably reduced with the 
use of these statistical techniques.
For the future therefore it is worthwhile considering 
a more general use of multivariate discrimination techniques 
as an aid to the recognition of normal as well as specific
diseases. The use of these statistical techniques can 
also provide important information about the diagnostic 
sensitivity of a given multitest profile. This would 
facilitate the optimisation of the tests in the profile 
for any given diagnostic problems.
SECTION 3 
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APPENDIX 1
Mean ±. 2 Standard Deviations
The' standard deviation is defined as the square root 
of the sura of squares of deviations of values from the sample 
mean divided by the number of degrees of freedom and for a 
sample may be calculated as:
s = / [ z  (x-x)2/(n-1)] = /  £  ^ H x 2 - fZx ) 2/n y/(n-1)j
in which the mean, x, is given by Zx/n.
The range x + 1.96-s describes the central 95 per cent 
of a sample Gaussian distribution, but for simplicity the 
range x + 2s is used and this corresponds to a probability 
of slightly more than 0.95*
The following sample statistics were computed using an 
Olivetti Programma 101 programmable, calculator:. 
the number of observations n; 
the mean x;
2
the variance of x, V(x) = s ;
the standard deviation s;
the variance of the mean V(x);
and the standard error of the mean SE(x).
APPENDIX 2
Percentiles
The use of the 2.5th and 97*5th percentiles eliminates 
5 per cent of the values (sample or population) and so the 
range can be directly compared with the mean + 2 standard 
deviations method.
Method
1. The observations are ranked in order from the lowest 
to the highest value.
2. The rank of the observation of the 2.5th percentile is 
given by 0.025(n+1) and if this estimate is not a whole number 
then linear interpolation is used between the two ranks which 
enclose the estimate. The precision of the percentile estimate 
is described in detail by Herrera (1958).
3. Estimation of the 97.5th percentile is made by ranking 
the observations in order from the highest to the lowest when 
the value of this percentile may be obtained by using the same 
rank number as that estimated for the 2.5th percentile.
Example using the urea distribution for unselected data 
Table 3.1 p. 155
N =757 ; .
.'. 2.5th percentile coincides with rank 758 x 2.5 = 18.95
100
Therefore the 97.5th percentile coincides with rank 757 - 18.95 
738.05.
the 18.95 observation = 2.5 percentile = 2.4 mmol/1.
.*. the 738.05 observation = 97.5 percentile = 11.2 mmol/1. 
Herrera (1958) calculated the percentiles from N + 1
observations as this gave a better unbiased estimate of a 
percentile.
The estimates of these percentiles (which are point 
estimates) can be accompanied by confidence intervals, 
(Elveback and Taylor, 1969-; Noether, G.K., 1967;
Mainland et al, 1963).
APPENDIX 3
Simple Cumulation
1. The range of values is divided into convenient intervals.
For a small amount of data, say up to 50 values, 7 or 8 
intervals should be used and for larger quantities of data 
between 8 and 20 intervals used. The number of intervals is 
based on the quantity of data and the considerations that if 
the values are grouped into too few intervals, information 
about the shape of the distribution may be lost and if the 
values are spread over too many intervals the subsequent 
mathematics becomes unnecessarily cumbersome. •
The intervals (also called cells, classes or groups) 
must be of equal width and continuous so that even if there 
is no data in one cell it is still included. •
Each cell is designated by its mid-point only.
2. A table (Table 3*1) is prepared with four columns headed:
Cell Mid-point ; Cell Frequencyj Cumulative Frequency* Cumulative 
Percentage.
The cell mid-points (x) and frequencies (f) are derived 
from the data and the cumulators calculated as Zf. Each 
successive value is then tabulated. The cumulators are expressed 
as percentages of the total quantity of data n in the last column.
3. These percentages are plotted on linear-probability paper 
(Fig 3.1) and'if the plotted points follow a reasonable straight 
line then the distribution approximates to a Gaussian distribution. 
The line, whether Gaussian or otherwise, is called the working line.
4Table 3.1 Data Set for the Urea Distribution of Unselected Patients
1. Cell 2. Cell 3. Cumulative 4. Cumulative
Midpoint Frequency Frequency Percentage
1.5 2 2 0.26
2.0 8 10 1.32
2.5 28 38 5.02
3.0 31 69 9.11
3.5 56 125 16.51
4.0 55 180 23.78
4.5 64 244 32.23
5.0 100 344. 45.44
• 5.5 74 418 55.22
6.0 58 476 62.88
6.5 56 532 • 70.28
7.0 59 591 78.07
7.5 33 624 82.43
8.0 23 647 85.47
8.5 19 666 87*98
9.0 22 688 90.88
9.5 21 709 93.66
10.0 , 14 723 95.51
10.5 8 731 96.57
11.0 7 738 97.49
11.5 4 742 98.02
12.0 7 749 98.94
- 12.5 8 757
4. The mean or the average value, x, is given at the point 
where the working line crosses the 50 per cent probability- 
line and the value x is read from the linear scale. This 
measures the median rather than the mean but these two 
statistics are identical if the data follows a Gaussian 
distribution.
5. Percentile estimates or probability limits may be 
directly obtained from the intersection of the working line 
with the probability line.
6. Waid’s estimates of normal limits may be obtained
by drawing a straight line through as many points as possible, 
giving greatest weight to those points about the median, and 
noting the two values of x where this straight line deviates 
from the working line.
7. The method of Hoffman used the same straight line as Waid 
but where necessary extrapolated this line to the 5 per cent 
and 95 per cent probability lines where the corresponding 
values of x gave the normal range limits.
8. Estimates of the standard deviation can be obtained from 
the relationships:
s^  = (84.13 per cent probability - 15.87 per cent probability)/2 
and Sg = (97.72 per cent probability - 2.28 per cent probability)/4 
where the linear scale readings are inserted for the appropriate 
probability values. If the distribution is Gaussian then the 
same value will be obtained for s^  and s^. By reference to the 
standard Normal distribution tables any number of relationships 
can be devised to cover different parts of the distribution.
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APPENDIX 4
Cyclic Cumulation
1. The range of values is divided into convenient class 
intervals in exactly the same manner described in appendix 3.
2. A table with four columns is again prepared, and these 
are headed: - Cell Midpoint, Cell Frequency, Cyclic Cumulator, 
Percentage. The first two columns are identical with those 
columns in Table 3.1. Each value in the cumulator is the
sum of the current cell frequency plus twice the sum of all 
the previous cell frequencies; the last value in the cyclic 
cumulator is double the total number of values, (Table 3.2) i 
This total does not correspond to any cell though it permits 
.calculation of a cumulative percentage other than 100 for the 
last cell.
3. The cyclic cumulation percentages are calculated, plotted 
on linear-probability paper and the 1 normal1 ranges derived as 
described in appendix 3.
Table 3.2 Calculation of Cyclic Cumulation Percentages for 
Urea Data on Unselected Patients
Cell Midpoint Cell Cyclic Percentage
Frequency Cumulator
0 0
1.5 2 2 0.13
2.0 8 12 0.8
2.5 28 48 3.2
3.0 31 107 7.0
3.5 56 194 12.8
4.0 55 305 20.0
4.5 64 424 28.0
5.0 100 .588 38.8
5.5 74 762 50.3
6.0 58 894 59.0
6.5 56 1008 66.6
7.0 59 1123 74.2
7.5 33 1215
CVJ*oCO
8.0 23 1271 83.9
8.5 19 1313 86.7
9.0 22 1354 89.4
9.5
*
21 1397 92.3
10.0 14 1432 94.6
10.5 8 1454 96.0
11.0 7 1469 97.0
11.5 4 1480 97.75
12.0 7 1491 98.5
12.5
Q
1506 99.5
757 1514
APPENDIX ' 5
Transformation Method
As described in appendix 3, the observations, n, are 
grouped into suitable class intervals described by their 
mid-points. The cumulative percentages are then calculated 
and the results plotted against the mid-points on logarithmic 
probability paper. If this paper is not available then each 
mid-point is converted to its logarithm and the cumulative 
percentages plotted against the logarithmic transform of the 
mid-points on linear probability paper. A straight line is 
drawn through these points and the required probability interval 
for the ■normal range observed. An example of logarithmic 
transformation is given in Pig 3.2.
This method is used only for those distributions which 
do not already approximate to a Gaussian distribution and have 
a right-sided skew. If the distribution has a left-sided skew 
then log (K-x) must be used to convert the mid points (x) to a 
suitable form, where k is a number greater than the largest 
value of x.
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APPENDIX 6
Hardings Graphical Method (1949)
1. ' This method was possibly the first to use the probability
paper designed by Hazen (1914), for the analysis of bimodal or
polymodal distributions. A bimodal or polymodal distribution
produces a curve when plotted on probability paper which may
be the resultant of two or more straight lines corresponding
to two or more Gaussian components. To resolve these
components inflexion points are identified arbitrarily.
These inflexion points are assumed to result from the overlap
of two Gaussian components. The position of an inflexion
point determines the ratio of the two Gaussian components and
can be read off the probability axis of the probability paper,
e.g. 30 per cent : 70 per cent. Each of the points in the
30 per cent part of the composite distribution is then
multiplied by 100 and replotted, and similarly each of the 
30
points in the 70 per cent component is multiplied by 100 and
70
replotted. The point of inflexion therefore becomes the 100 
per cent point for one component and 0 per cent for the other.
If the resulting points approximate to a straight line then 
the line is drawn to represent the Gaussian component.
If the resulting points do not approximate to a straight 
line then another point of inflexion is identified and the 
process continued. Thus, each parent curve is firstly treated 
as bimodal and the analysis is continued until all of the data 
fits straight line Gaussian components. The resolved components 
are then combined and subjected to the Chi-square test to ensure 
that unacceptable distortions of the original data have not been 
introduced.
Example of Harding*s Method Combined with the Chi-square Test
The potassium data for unselected patients is used in 
this example and table 3.3 shows the calculated cumulative 
percentages and Pig 3.3 the original distribution on probability 
paper. The curve is sigmoidal and therefore can be divided 
into four components with three obvious points of inflexion.
Table 3.3 Calculation of Cumulative Percentages for the 
Potassium Data from Unselected Patients______
Cell Cell
Mid-point Cumulative Cumulative Mid-point Cumulative Cumulative
x q Frequency Percentage x q Frequency Percentage
2.15 2 0.09 3.95 554 40.4
2.35 3 0.22 4.15 718 56.0
2.55 7 0.44 4.35 891 70.9
2.75 . 11 0.79 ' 4.55 1000 83.3
2.95 30 1.81 4.75 1058 90.7
3.15 59 3.9 4.95 1093 94.8
3.35 109 7.4 5.15 1114 97.2
3.55 212 14.1 5.35 1125 98.6
3.75 364 25.4 5.55 1135 99.6
The first point of inflexion at the 90 per cent probability
rel when dissected produces a 90 per cent subset of frequencies
1022 observations and a 10 per cent subset of frequencies of
113 observations. Table 3.4 shows the resolved subsets and 
their calculated cumulative percentages. These are again 
plotted on probability paper (Fig 3.4).
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Xq = 0.2x* + 1.95 mmol/l.
Table 3»4 Resolved Components of Unselected Potassium Data 
using the Method of Harding; Calculation of 
Component Cumulative Percentages
90 per cent Component 10 per cent Comoonent
Mid point x0 f Percentage Mid point Xn f Percentage
2.55 7 0.7 4.75 36 31.9
2.75 4 1.1 4.95 35 62.8
2.95 19 2.9 5.15 21 81.4
3.15 29 5.8 5.35 11 91.2
3.35 50 10.7 5.55 10
3.55 103 20.7
3.75 152 35.6
3.95 190 54.2
4.15 164 70.2
4.35 173 87.2
4.55 109 97.8 -
4.75 22
Straight line Gaussian components are drawn through these 
points and the modified percentages corresponding to the mid 
points are read from these lines. These percentages are 
converted to cumulative frequencies and for each class interval 
the cumulative frequencies of the resolved components added 
together in order to restore a single total distribution. By 
subtracting one cumulative frequency from the next the cell 
frequencies for the sum of the resolved components can be calculated 
and compared with those of the original distribution using the 
Chi-square test Table 3*5.
Fig, 3,4 RESOLUTION of TINS ELECTED POTASSIUM DATA - HARDING'S METHOD
2 3 4 5 6 7 8 9 10 11 12 11 14 15 i6 17 18
x*
x^> s= 0.2x' + 1,95 mmol/l.
;v •'
Table 3.5 i Data Set 1 : Chi-square Test on Two-Component
i
Split of Unselected Potassium Data
Mid Frequency 
point
X
90% Subset 
% Frequency
10% Subset 
% Frequency
Total
Subset
Cumulative
Frequency
Frequency
2.15 2 - - 0
2.35 1 - 0
2.55 4 0.3 - -5 0
2.75 4 1.0 10 10 10
2.95 19 2.9 30 30 20
3.15 29 6.5 66 66 36
3.35 50 13.0 133 133 67
3.55 103 22.0 " 225 225 92
3.75 , 152 37.5 383 0.2 - 383 158
3.95 190 53.0 542 1.0 1 543 160
4.15 164 68.5 700 3.0 3 703 160
4.35 173 82.0 838 9.0 10 848 145
4.55 109 90.0 920 21.0 24 944 96
4.75 58 95.5 971 40.0 - 45 1016 72
4.95 35 98.0 1002 61.0 69 1071 55
5.15 , 21 99.6 1018 79'. 0 89 .1107 36
5.35 11 99.8 1020 91.0 103 1123 16
5.55 ' 10 99.95 1022 97.0 113 1135 12
Because the frequencies of the :first four classes are less than 10 in
the resolved idistribution, the first four classes are combined so that
ro II I 10) /10 + (19-20)2/20 4• (29-36)2/36 + (50-67)2/67
+ (103-92)2/92 + (152-158)2/158 + (190- 160):”/160 + (164-■160) 2/l60
+ (173-145) 2/145 + (109-96)2!/96 + (58-72)2/72 + (35-55) 2/55
+ (21-36)2/36 + (11-16)2/l6 + (10-12)2/12
= 38.4 with 15- 6 = 9 Degrees of Freedom •
PorX20, with• 05 9 degrees of freedom, values above 16.92 show that
the two distributions are not sufficiently similar to accept the
resolved components. A further analysis of the data must therefore 
be performed.
Referring to Fig 3*3 ,  the original distribution plot, 
four components can be resolved corresponding to 1 per cent, 
9 per cent, 80 per cent and 10 per cent subsets. The 
distribution is therefore dissected and tested against the 
original in a second attempt at resolving satisfactory 
Gaussian components. Table 3.6 shows the calculations and 
Fig 3 . 5  the four components.
Table 3.6 Chi-square Test on Four Component Split *
Original 1 % 9% 80% 10% Total
Distribution Component Component Component Component Component
X0 cf
cum
%
cum 
cf % cf
cum
% cf
cum
% cf
Frequency
2.15 2 14.0 2 2
2.35 1 36.0 2 2
2.55 4 64.0 3 3
2.75 4 85.0 3 .*■ 3
2.95 19 96.0 1 11.0 11 0.4 4 15
3,15 29 6 0.0 50 1.6 11 61
3.35 50 96.5 38 5.0 30 68
3.55 103 99.9 3 13.5 78 81
3.75, 152 28.0 131 0.06 131
3.95 190 48.0 182 0.6 1 183
4.15 164 68.0 181 1.8 1 182
4.35 173
o•ir\CO 155 7.0 6 161
4.55 109 94.0 82 18.5 13 95
4.75 58 98.0 36 38.0 _22 58
4.95 35 99.5 13 61.0 26 39
5.15 21 • 5 80.0 22 ' 27
5.35 11 92.0 •13 13
5.55 10 ■ 97.5 7 7
The first four and last two class interval frequencies are 
combined so that 
X f  = (11 -10) 2/10 + (19-1 5)2/15 + (29-61) 2/61 + (50-63)2/68
+ (103-81) 2/81 + (152-131)2/ 1 31 + ( 190-18 3 )2/ 1 83 + (164-182)2/182 
+ (173-161)2/i61 + ( 1 0 9 -9 5 )2/95 + ( 5 8 -5 8 )2/5 8  + (3 5 -3 9)2/39  
+ ( 2 1 -2 7 )2/27  + (2 1 -2 0 )2/20  
' =  -38.8
This resolution process must again be rejected. However, it 
can be seen that 2*7*5* of the total X2 . score is contributed
COMK)KENT SPLIT - HARBIN’S METHOD.
i
a
X0 = 0o2x* -f 1 .95 mmol/l
17 18
— ----------9 per cent component acceptable
by the class intervals 3*15, 3.35 and 3.55‘. On examination 
of the component contributing most to these class frequencies 
it is seen that the 9 per cent component responsible has only 
three points from which to draw the Gaussian subset. If 
another line is drawn as shown (dotted line) on Pig 3.5 and 
the Chi-square test repeated, the resolution process becomes 
acceptable for the 95 per cent level of significance, Table 3.7.
Table 3.7 Chi-square Test for the Modified 4-Component Split
Original 
Distribution 
x q  Frequency
1 %
Component
Frequency
9%
Component
Frequency
80%
Component
Frequency
1 0 %
Component
Frequency
Total
Component
Frequency
2.15 2 2 2
2.35 1 2 2
2.55 . 4 3 1 • 4
2.75 4 3 5 • 8
2.95 19 1 14 4 19
. 3.15 29 20 ' 11 31.
3.35 50 25 30 . 55
3.55 103 25 78 103
3.75 152 7 132 139
3.95 1 9 0 5 182 1 188 .
4.15 . 164 181 1 182
4.35 173 155 6 -1 C  -11 VJ 1
4.55 109 82 13 95
4.75 58 36 22 58
4.95 . 35 13 . 26 39
5.15 ’ 21 .5 22 27
5.35 11 13 13
5.55 10 7. 7
Combining the first four and last two class frequencies
= ( 1 1 -1 6 )2/16 + (19—19)2/ 1 9 + ( 2 9 -3 1 )2/31 + ( 50 -55 )2/55  
+ (103-103)2/103 + (1 52 -139 )2/139 + ( 190-188)2/188 + ( 164-182)2/182 
+ (173-161)2/161 + (1 0 9 -9 5 )2/9 5  + (5 8 -5 8 )2/58  + ( 3 5 -3 9 ) 2/39 
+ (2 1 -2 7 )2/27  + ( 2 1 -2 0 )2/20 
= 9.9
2'q for 15-11 degrees of freedom = 9*5.  The calculated 
value for with 4 degrees of freedom provides a probability 
P between o.o6\ and 0.04- and this suggests that the goodness of 
fit between the resolved and original data sets is not excellent 
but that deviations have been reduced to an acceptable level.
The 2.5 percentile and 97.5 percentile estimates of the 
normal range are 3.2 mmol/1 to 4.7 mmol/1.
APPENDIX 7
Method of Becktel (1970)
This method assumes that the bulk of the data is from a 
Gaussian distribution and that abnormal values appear only 
at one end of the distribution and it is known which end these 
abnormal values appear.
The mean is estimated as either the point of greatest
concentration of observed values (the mode) or the median
whichever is further from the end known to contain the 
•abnormal results.
The standard deviation is estimated as the difference 
between the estimated mean and the average of six specified
percentiles located at the normal end of the distribution,
e.g. the 5th, 10th, 15th, 20th, 25th and 30th "percentiles where 
the abnormal component is at the right side of the' distribution.
Estimation of the Mean *
The n observations are ranked in order of magnitude from
the smallest, X„ to the largest X .* 1 ° n
J is found which is the largest odd number not greater
than N/2. The differences X^ . - X^ ; - X^
... X - X -.1 „ are then calculated and if there is a unique n n-J+1 n
smallest difference, say - ^20* ^ en the mean is taken to
be at rank jTj  + 20) + 20^ If there are several ranks with 
the same smallest difference then the average of these ranks 
is taken for the calculation of the mode. If the rank of the 
calculated mode is on the abnormal side of the median then 
the median and not the mode is taken as the mean. A graphical
method for determining the smallest difference has been devised.
Estimation of the Number of Normal Values
When the mode is used as the estimate of the mean then
the estimate of the number of normal values is based on
equal numbers of observations below and above the mean. If
is the mode, and therefore the mean, then there are 41 42 .
normal observations below the mean and 41 normal 
observations above the mean so that the total number of 
uncontaminated values, N , is Nu = 41 +41 + 1 =83. If the 
data is such that the median is the estimate of the mean then
Nu = n - ■
Estimate of the Standard Deviation
This is based on N ., the total number of uncontaminated 
values. For tests with low abnormal results the difference 
between the mean and the average of the 70th, 75th, 80th, 85th*
90th and 99th percentiles is taken as one standard deviation 
while for tests with high abnormal results then the difference 
between the mean and the average of the 5th, 10th, 15th, 20th,
25th and 30th percentiles is taken as one standard deviation.
When the desired percentile lies between two observations
linear interpolation is used, for example, XQ , - X0 + 0.3(Xn - XQ).
o • j o y o
The use of percentile relationships or linear order 
statistics to estimate the standard deviation was first 
investigated by Mosteller (1946) and later tested by Venter (1967). 
Mosteller devised conditions which produced a consistent estimate 
of the standard deviation and gave the specific example of:
*X0 .97N+X0.97N+X0.8 5N+X0.7 5N*X0.2 5N“X0.15N~X0 .08N~X0.02N ^ 
divided by 10.34. The constant 10.34 is the expectation of
the numerator (for large N) divided by the standard deviation.
Any number of these relationships can be devised and Becktel (1970)
used - (X0.30N + X0.25N + X0.20N + X0.15N + X0.10N + X0.05N^1 ^  6.03.
This is the relationship used in the method of Becktel, the only 
modification being the cancellation of the constant 6.03 and the 
coefficient of the meanji.
Becktel tested his method using samples of N = 100 a*id 
deliberately contaminating -the distributions with 10, 20 and 
30 per cent abnormal values.- He found only a slight bias 
of the mean towards the abnormal values with a slight 
increase in standard deviation.
Worked Example of the Method of Becktel
The Urea unselected data contains 757 observations from 
which n/2 = 378.5 so that J = 377. Tabulating 376 differences 
is cumbersome so Table 3*8 has been devised to simplify the 
observation of the smallest differences.
The smallest difference in pairs of observations is 2.5 
and this occurs in all pairs from
X415 X39 t0 X418 ~ x42» x446 " X70 to x476 " x100»
x492 “ X126 t0 x532 “ x156» x557 ” X181 to x591 “ X215’
X260 " X244 t0 X624 ~ X248
that is, in 116 pairs of observations. The average rank of 
the 232 observation is 
4(415 + 418/2 + 4(39 + 42)/2 + 31(446 + 476)/2 + 31(70 + 100)/2 
+ 41(492 + 532)/2 + 41(126 + 156)/2 + 35(557 + 591)/2 + 35(181 + 215)/2 
+ 5(620 + 624)/2 + 5(244 + 248)/2 / 232 = 331.4
and Table 3.8 shows that ranks 245 to 344 have values of 5.0
Table 3.8 Method of Becktel: Calculation of Smallest Differences
mid-point x 
mmol/1
1.5
2.0
2.5
3.0
3.5
4.0
4-5
5.0
Rank Rank 
2 
10
38
69
125
180.
244
344
418(42).
476(100)
■532(156)
591(215)
.624(248)
647(271)
■-666(290)
377
757
mid-point x 
mmol/I
5.5
.6.0
6.5
7.0
7.5
8.5
9.0
Figures in parentheses are the 
corresponding ranks on the 
opposite side.
so that 5*0 is taken as the value of the mode.
The median has rank 379 which has a value of 5*5. The 
abnormal values are known to be at the high value end of the 
range so that the mode is taken as the estimate of the mean 
and we have mean = 5.0* The estimate of the standard 
deviation is given by-
mean - ( 5 +  1 0 +  1 5 + 2 0 + 2 5 . +  30 percentiles)/6 
or mean - (R28.75 + R57.5‘+ R86.25 + R115 + R143.75 + R172.5)/6 
which is 5.0 - (2.0 + 3.0+ 3.5 + 3.5 + 4.0 + 4.0)/6 = 5.0 - 3.3 
and the normal range is 5.0 + 2 x 1.6 = 5 . 0  + 3.3 = 1.6 to 8.3*
APPENDIX 8
Bhattacharyats Method
The experimental data are divided into cells (or classes)
of equal width (the class interval) and each cell is identified
by its mid-point, x q. Then
let y (x^) denote the observed frequency in the cell which has
x^ as its midpoint, and 
h denote the class interval,
and the procedure is to plot y(x^ + h)/y (x^)
vs. x^ on semi-log graph paper, or 
log y = log y(xi + h) - log y(xj[)
vs. x^ on ordinary linear graph paper.
Those regions where the graph looks like a straight line 
with negative slope indicate separate Gaussian 
components, and if the straight lines are drawn the parameters 
may be calculated for each component.
If is the intercept on the x-axis made by the r-th
straight line, values of the parameters are calculated using 
the relationships:the mean value of the rth component is
rT = r\T + h/2 . . .  (1)
2 2 
and the variance of the rth component is ~ hAx/A. (A  lny)-h /12 ..(2)
2in which the term h /12 is Sheppard's correction for grouping.
It should be noted that Bhattacharya drew his 'best fit' 
straight lines by eye, and measured the angle between each 
line and the x-axis. Then using scalar dimensions and tables 
of tangents he converted the measurements to the required 
items. For example, if 0* is the angle between the rth 
straight line and the x-axis, it follows that since the
graph of ZA log y^ vs. x^ is a straight line with negative 
slope equal to -hJjj^ — h^/1^J/cf^ and if it has been 
necessary to choose different scales for x and log y, say 
b and d respectively, then the slope becomes 
- dh P  - h2/12j / (b cr^ ) which equals - tan 0^, from
which b tan O' - d"2 + h2/12 = 0r _______r r
dh
. j
or, for simplicity substituting b tan # r/dh = a gives
atf4  - cT2 + h2/12 = 0r r
whence cT2 = ~ - h2/12 = dh - h2/12 = h.A x - h2/12
b tan 0-^ A( A lny)
V/orked Example of the Method of Bhattacharya for Resolving a 
Distribution into Gaussian Components
The urea distribution of unselected data"is used for this
example. Firstly, a table was constructed (Table 3.9) for the
calculation of log^y.
These values were plotted on ordinary graph paper against
x, the mid-point of the class interval, Fig 3.6.
- The best straight lines with negative slopes were then
fitted by eye. However, it can be seen that except for the 
lines shown.a.number of points do not fit a
good straight line. Fig 3.7 shows the same data grouped into 
wider class intervals (h = 1 mmol/1). The bulk of the data 
now approximate to a straight line although the fit is still poor. 
The mean of this Gaussian component was calculated from
4Table 3.9 Calculation of A l o g ^ y  for Bhattacharya's Method
Mid-point of , Observed Log^y A log1Qy
Class Interval x Frequency y ______  ________
1.5 2 0.301 +0.602
2.0 8 0.903 +0.544
2.5 23 1.447 +0.044
3.0 31 1.491 +0.257j
3.5 56 1.748 -0.008
4.0; 55 1.740 +0.066
4.5 64 1.806 +0.194
5.0  100 2.000  - 0.131
5.5 74 1.869 -0.106
6.0 58 1.763 -0.015
6.5 56 1.748 +0.023
7.0 59 1.771 -0.252
7.5 33 1.519 -0.157
8.0 23 - 1.362 -0.082
8.5 19 1.279 +0.063
9.0 22 1.342 - 0.020
9.5  ' 2 1  1.322  - 0.176
10.0 14 1.146 -0.243
10.5 8 0.903 -0.058
11.0 7 0.845 -0.243
11.5 4 0.602 +0.243
12.0 7 0.845 +0.058
12.5 8 0.903
Pig, $06 Bhattachaxya1 s Resolution of Unselected
TJrea Data
1.0
h e 0.5 mmol/l
10 11 mmol/l
H
0.5
Pig. 3#7 Bhattacharya1 s Resolution of Unselected
Urea Data
1o0
h a 1,0 mmol/l
0.5
1o0
The standard deviation for this component was 
(5"i = [ h x A x  - Y?J A  ( A. 1ny) 12
= /l.O x (6.7 - 2.7) -  
/I 2.3026 (0.32 + 0.31) 12
= /l.O x 4.0 —  1
/I 1.45 12
J
= 1.64 
2tf^ = 3.28
Therefore the x + 2^j range was 5.2 + 3.3 = 2.0 to 8.5 mmol/l
Appendix 9 The Kolmogorov-Smirnov Test for the Identification
of Differences in the Frequency Distributions • 
between Specific Age and Sex Groups
In the Kolmogorov-Smirnov test (Kolmogorov, 1933;
Smirnov, 1939; Scheffe, 1943 and Wolfowitz, 1949) the cumulative 
frequencies are calculated for both frequency distributions and 
the differences between the cumulative frequencies for each class 
interval noted. The greatest difference is divided by the 
total number of observations and compared with the limit values 
in Table 3.10 (Massey, 1957 and Lilliefors, 1967).
Table 3.10 Critical Values of the Maximum Absolute Difference 
between Cumulative Frequencies
Sample Size Levels of Significance
'<£) 0.2 0.1 • 0.05
5 * 0.45 0.509 0.563
10 0.32 0.369 0.409
15 0.27 0.304 0.338
20 0.23 0.265 0.294
25 0-21 0,238 0.264
30 0.19 0.218 0.242
35 - 0.18 0.202 0.224
> 3 5 1.07/Vn 1.22//n 1 • 36/vrn
For acceptance at a given level of probability the calculated 
value needs to be less than the tabulated value.
Example using Albumin data for Male Subjects in the 
1 1 - 2 0  and 21 - 30 .year groups
11 - 20 year group 21 - 30 .year group
Mid point of frequency cumulative frequency cumulative Differenc
Class Interval frequency frequency d
30 0 0 2 2 2
32 7 7 3 5 2
34 5 12 2 7 5
36 11 23 7 14 9
38 10 33 9 23 10
40 23 56 24 47 9
42 38 94 40 • 87 7
44 46 140 44 131 9
46 52 192 56 187 5
48 33 225 33 222 3
50 9 234 10 - 232 2
52 0 234 2 23^ 0
Largest difference d = 10 & max
= 10/234 = 0.043
IQw >a
Critical value for d at the 5 per cent level of significance
is dA = 1.36//234 = 0.089 (Table 4.0)u.up
Therefore the two distributions are not considered different 
at this level of significance.
APPENDIX 10
A Brief Description of the Principle of Discrimination Techniques 
The ellipsoids (Pig 3.8) represent bivariate distributions 
of two variables and x^ in two groups. If viewed from 
each axis then the degree of overlap of the ellipsoids is 
large and the frequency of misclassification will also be 
large. However, if the two ellipsoids are viewed from 
the direction A-A and projected onto line B-B then the 
degree of overlap is reduced and so therefore is the 
frequency of misclassification. Thus it can be seen that 
a bivariate analysis on each two populations has been reduced 
to a single dimension or discriminant represented by line B-B. 
This geometric interpretation may be extended to more than 
two variables in a multidimensional space. •
Pig. 3.8 Geometric Interpretation of Discriminant Analysis
The mathematics are complicated and if the number of variables 
exceed 5 and the number of groups (in this case diseases) 
requiring differentiation exceeds 2 then computer facilities 
are necessary.
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